###begin article-title 0
###xml 59 67 <span type="species:ncbi:9606">patients</span>
An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types
###end article-title 0
###begin p 1
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 336 344 <span type="species:ncbi:9606">patients</span>
###xml 718 725 <span type="species:ncbi:9606">patient</span>
###xml 936 944 <span type="species:ncbi:9606">patients</span>
Wiskott-Aldrich syndrome (WAS) predisposes patients to leukemia and lymphoma. WAS is caused by mutations in the protein WASP which impair its interaction with the WIPF1 protein. Here, we aim to identify a module of WIPF1-coexpressed genes and to assess its use as a prognostic signature for colorectal cancer, glioma, and breast cancer patients. Two public colorectal cancer microarray data sets were used for discovery and validation of the WIPF1 co-expression module. Based on expression of the WIPF1 signature, we classified more than 400 additional tumors with microarray data from our own experiments or from publicly available data sets according to their WIPF1 signature expression. This allowed us to separate patient populations for colorectal cancers, breast cancers, and gliomas for which clinical characteristics like survival times and times to relapse were analyzed. Groups of colorectal cancer, breast cancer, and glioma patients with low expression of the WIPF1 co-expression module generally had a favorable prognosis. In addition, the majority of WIPF1 signature genes are individually correlated with disease outcome in different studies. Literature gene network analysis revealed that among WIPF1 co-expressed genes known direct transcriptional targets of c-myc, ESR1 and p53 are enriched. The mean expression profile of WIPF1 signature genes is correlated with the profile of a proliferation signature. The WIPF1 signature is the first microarray-based prognostic expression signature primarily developed for colorectal cancer that is instrumental in other tumor types: low expression of the WIPF1 module is associated with better prognosis.
###end p 1
###begin title 2
Electronic supplementary material
###end title 2
###begin p 3
The online version of this article (doi:10.1007/s00109-009-0467-y) contains supplementary material, which is available to authorized users.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 847 848 847 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 937 938 937 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 940 941 940 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 1260 1262 1260 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
###xml 1075 1080 <span type="species:ncbi:9606">human</span>
The WIPF1 gene encodes the WASP/WASL interacting protein family member 1 that plays an important role in the organization of the actin cytoskeleton [1, 2]. The WIPF1-encoded protein WIP binds to a region of Wiskott-Aldrich syndrome protein (WASP) that is frequently mutated in patients with Wiskott-Aldrich syndrome (WAS) [3, 4], and WIP mutations themselves lead to an immunological disorder resembling Wiskott-Aldrich syndrome [5]. WAS is an X-linked recessive disease that predisposes to leukemia and lymphoma. The WIP protein is essential for WASP synthesis and probably acts as its chaperone [6]. Disruption of the WASP-WIP interaction by hereditary mutations leads to a rounded cell surface on immune cells, a conversion that is thought to coincide with a diminished capability to form immune synapses and reduction of NK cell cytotoxicity [7]. WIP is important for podosome formation in macrophages and cellular fusions in flies [8, 9], stressing its universal role in the design of cell membrane remodeling. Apart from its expression in diverse immune cells, several human tissues exhibit WIP expression. Little is known about the expression of WIPF1 in solid tumors. However, WIPF1 expression levels influence morphology and migration of fibroblasts [10]. This prompted us to investigate the expression characteristics of WIPF1 in colorectal tumors with the aim to study its potential for prognosis.
###end p 6
###begin p 7
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 844 851 <span type="species:ncbi:9606">patient</span>
A multitude of microarray studies have been carried out during the past decade to gain a better understanding of basic colorectal cancer (CRC) biology [11-18]. Other CRC microarray studies led to the discovery of informative gene sets for the prediction of the response to therapy or tumor recurrence [19-23], diagnosis of tumor stage [24-27], lymph node metastasis [28-30], or liver metastasis [31, 32]. Until now, cross-validation of diagnostic or prognostic signatures with independent data sets has hardly been performed for colorectal cancer. This is probably due to the fact that published signatures are only overlapping to a small degree and that they are difficult to reproduce when originating from different laboratories and platforms (for a discussion see Groene et al. [24]). In addition, until recently, data sets with sufficient patient information were lacking in public databases which hindered cross-validation of signatures from different studies.
###end p 7
###begin p 8
###xml 556 564 <span type="species:ncbi:9606">patients</span>
###xml 713 721 <span type="species:ncbi:9606">patients</span>
###xml 831 839 <span type="species:ncbi:9606">patients</span>
###xml 965 973 <span type="species:ncbi:9606">patients</span>
###xml 1174 1182 <span type="species:ncbi:9606">patients</span>
Here, we describe the identification of a set of genes that is co-expressed with WIPF1. It was discovered through re-analysis of two public microarray data sets on clinical colorectal cancer specimen that were deposited in the Gene Expression Omnibus (GEO) database (). Whereas the first data set was used for discovery of WIPF1-coexpressed genes, the second data set served us for validation of the expression correlations. Using a simple classification algorithm trained on microarray data of WIPF1 co-expressed genes from the two studies, we identified patients with characteristic expression of the WIPF1 coexpression module in three further microarray data sets with information about survival or relapse of patients: a colorectal cancer data set of our own, a breast cancer data set, and a glioblastoma data set. Strikingly, patients with low expression of the WIPF1 signature have the best prognosis in all three data sets, in total comprising more than 400 patients. Based on an analysis of the WIPF1 coexpression module in the context of literature-based gene networks, we identified plausible regulatory mechanisms responsible for lower WIPF1 module expression in patients with better prognosis.
###end p 8
###begin title 9
Materials and methods
###end title 9
###begin title 10
Sample acquisition
###end title 10
###begin p 11
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">1</xref>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
###xml 285 293 <span type="species:ncbi:9606">patients</span>
###xml 435 443 <span type="species:ncbi:9606">patients</span>
For the generation of our own microarray data set, 62 CRC patients undergoing elective standard oncological resection at the Department of General, Vascular, and Thoracic Surgery, Campus Benjamin Franklin, Charite, were prospectively recruited. Several clinical characteristics of the patients were recorded (see Supplementary Table 1). The study was approved by the local ethical committee, and informed consent was obtained from all patients.
###end p 11
###begin title 12
Laser-capture microdissection
###end title 12
###begin p 13
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 1067 1068 1063 1064 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Pre-processing of frozen tissue blocks by laser-capture microdissection was essentially performed as described in our previous publications [13, 14, 24, 33]. Briefly, all cancer specimens were snap frozen within 20 min following excision. After laser-capture microdissection frozen tissue specimens were serially cut into 6- to 8-microm-thick sections which were mounted on a sterile 2.5 mm membrane. Slides were fixed in 70% ethanol. The sections were briefly stained with hematoxylin and eosin, dehydrated in ethanol, and dried for 10-15 min using an exsiccator. The membrane was turned around and fixed with adhesive tape on the other sterile slide. First slides served as a template on which the areas of tumor or normal epithelium were marked. On the consecutive section, these areas were microdissected using a laser microdissection system (SL, Jena, Germany and P.A.L.M. Microlaser Technologies AG Bernried, Germany) and capture transfer films (Arcturus GmbH, Moerfelden-Walldorf, Germany). For molecular analysis, up to 100,000 cells or approximately 30-60 mm2 of tissue section areas were pooled and collected in ice-cooled tubes containing 100 ml of 98% guanidine thiocyanate (GTC) buffer and 2% beta-mercaptoethanol.
###end p 13
###begin title 14
Messenger RNA preparation and DNA chip hybridization
###end title 14
###begin p 15
PolyA mRNA from the microdissected specimens was prepared using the PolyA-tract 1000 kit (Promega, Heidelberg, Germany) according to the manufacturer's recommendations. For each sample, the cDNA synthesis and repetitive in vitro transcription were performed three times. The total amount of prepared mRNA from each sample was used. First strand cDNA synthesis was initiated using the Affymetrix T7-oligo-dT promoter-primer combination at 0.1 mM. The second strand cDNA synthesis was generated by internal priming. In vitro transcription was performed using the Megascript kit (Ambion, Huntington, UK) as recommended by Ambion. From the generated cRNA, a new first strand synthesis was initiated using 0.025 mM of a random hexamer as primer. After completion, the second strand synthesis was performed using the Affymetrix T7-oligo-dT promoter-primer combination. A second in vitro transcription was performed, and then the procedure was repeated one additional time. During the last in vitro transcription, biotin-labeled ribonucleotides were incorporated into the cRNA, as recommended by the Affymetrix protocol. Hybridization and detection of the labeled cRNA on the Affymetrix U133A Chip were performed according to Affymetrix standard protocol.
###end p 15
###begin title 16
Microarray data pre-processing
###end title 16
###begin p 17
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
###xml 707 715 <span type="species:ncbi:9606">patients</span>
###xml 785 792 <span type="species:ncbi:9606">patient</span>
Public expression data was downloaded from the Gene Expression Omnibus (GEO) database (). In addition to our own data that was deposited in GEO with accession number GSE12945, we used four different data sets from this repository. The colorectal cancer data sets GSE5206 of the Aronow group (see Kaiser et al. [17]), GSE7208 of Ayers and co-workers [20] and of our own served us for discovery and validation of the WIPF1 signature in CRC. The GSE2034 data set of Wang et al. served us for assessment of predictive power of the WIPF1 signature for breast cancer patients [34]. The data set of Phillips et al. (GSE4271) served us for assessment of predictive power of the WIPF1 signature in high-grade glioma patients [35]. We refer to the original publications and the GEO database for patient and sample characteristics.
###end p 17
###begin p 18
For our own microarray experiment, we used algorithms implemented in the freely available statistical software package R () and its public package repositories CRAN () and the bioinformatics R package repository Bioconductor (). Preprocessing: Raw expression data were condensed to probe set-wise intensity values using the RMA algorithm. For experiment normalization, all colorectal cancer data sets were pre-processed using the same data transformations. If not already done, the raw data were log transformed. Independently of the original authors' pre-processing, we quantile-normalized each data set on the probe set level. Then we filtered out the 10% probesets with lowest median expression and 10% probesets with lowest variance to enrich informative probesets in an unbiased way. We restricted the further analysis to probesets passing this filter in each of the three data sets. Probeset annotations for Affymetrix expression microarrays (most importantly gene symbols) were retrieved from the Affymetrix web site (version 22). We condensed probeset signals on the gene symbol level by averaging across all remaining probesets of a gene. On the gene level, each data set was finally mean centered. Breast cancer and glioma data were processed in the same way: but here no additional probesets were filtered out due to low variance or mean expression signals in these data sets. Instead, for mapping of probeset expression intensities onto the gene level, we considered all probesets that were used for probeset-to-gene mapping during processing of the three CRC data sets. Using the applied normalization scheme, we intend to ensure that Affymetrix microarray data from the five different studies are comparable (we note that our study does not include a cross-platform comparison as all data sets were generated using Affymetrix gene chips).
###end p 18
###begin title 19
Expression data mining
###end title 19
###begin p 20
###xml 69 70 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRAN</italic>
###xml 123 135 123 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bioconductor</italic>
###xml 282 290 282 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cor.test</italic>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stats</italic>
###xml 347 348 347 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 568 586 568 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">signature centroid</italic>
###xml 732 741 732 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">heatmap.2</italic>
###xml 758 764 758 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gplots</italic>
###xml 862 883 862 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">correlation distances</italic>
###xml 885 886 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 902 903 902 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 904 905 904 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 1027 1043 1027 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">complete linkage</italic>
###xml 651 658 <span type="species:ncbi:9606">patient</span>
Expression data mining was carried out using the statistics software R supplemented with diverse packages from the CRAN or Bioconductor projects. Analysis of the correlation of two expression profiles was evaluated with Pearson correlation coefficients determined with the function cor.test in package stats. Using the same function we determined p values for the significance of the deviation of the correlation coefficient from 0. The average expression profile of a multigene expression signature (proliferation signature by Rosenwald et al. [36]), here denoted as signature centroid, was determined using averaging across signature genes for each patient. For tumor class discovery, we applied hierarchical clustering using the heatmap.2 function of the gplots package in R. The distance matrices for row and column clustering were determined using pairwise correlation distances (d = 0.5 (1 - cor(x,y))) of the gene-wise mean-centered expression intensities of genes and samples, respectively. For clustering, we used the complete linkage hierarchical clustering algorithm.
###end p 20
###begin p 21
###xml 449 454 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">class</italic>
###xml 465 468 465 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">knn</italic>
###xml 1249 1251 1249 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
In the preceding paragraph, we described how we identify tumor classes in a training data set using unsupervised analysis (clustering). Using classification (supervised analysis), we then attempted to detect the tumor classes that we identified on a primary (training) data set in tumors of secondary (test) data sets from independent studies. As a classification algorithm, we used k-nearest neighbor classification as implemented in the R package class (function knn with k = 9). The classifiers were trained on tumor expression profiles of the training data and then directly applied on test data sets. A prerequisite for our classifier to work properly on the test data (here solely external data sets from independent studies) is that training and test data are sufficiently normalized which in our study should be ensured by log-transforming the expression values followed by gene-wise mean centering. Across-study normalization based on intra-study mean centering of log-transformed expression intensities from Affymetrix chips was already shown by Lusa et al. to be a pre-processing strategy that can be the basis of good classifier performance when the aim is to construct gene expression-based predictors for tumor classes across studies [37]. However, the authors also stated that best classifier performance can only be expected if the fraction of tumor classes in the different data sets is comparable. In our own validation of our methodology, we found that k-nearest neighbor-based predictors of estrogen receptor status in breast cancers based on an estrogen-responsive set of genes achieves prediction accuracies on external data sets of ~90% on average on gene-wise mean-centered expression data (based on four Affymetrix U133A microarray data sets, data available upon request, manuscript in preparation). Classifier performance was still at 76% when the tumor classes were not balanced (e.g., 1:8 in test data). We note that we did not attempt to assess classifier accuracy using cross-validation on the primary data because we have derived the tumor classes by data mining in the complete primary data set: it is obvious that a numerical difference between classes exists. Therefore, the assessment of classifier performance using cross-validation could lead to a serious overestimation of classifier accuracy. The reason is that even if test cases in cross-validation are not used for classifier training, they were already included in the initial clustering analysis that led to the assignment of class labels: a violation of a main principle of cross validation-the independence of training and test data.
###end p 21
###begin p 22
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survfit</italic>
###xml 114 122 114 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survival</italic>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">coxph</italic>
###xml 193 201 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survival</italic>
###xml 540 545 540 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">coxph</italic>
###xml 650 656 650 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">robust</italic>
###xml 657 658 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 295 302 <span type="species:ncbi:9606">patient</span>
Patient survival and relapse were visualized with Kaplan-Meier curves determined with the survfit function in the survival package. The logrank test as implemented in the coxph function of the survival package was used to assess the significance of differences in survival/relapse times between patient groups. The significance of association of continuous variables, here gene expression intensities, with survival/relapse were tested using Cox regression and Wald tests on the model coefficients and their variances as implemented in the coxph function. For survival analyses, we used robust estimates of Cox model coefficient variances (parameter robust=T). If not otherwise indicated, default parameter settings were used in the functions mentioned above.
###end p 22
###begin p 23
###xml 632 633 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 667 672 <span type="species:ncbi:9606">human</span>
Literature-based gene networks were investigated using the metaCore software from GeneGo (Saxony Road, #104, Encinitas, CA 92024, USA). Subnetworks of genes with functional links based on literature evidence were screened for enrichment of genes co-expressed with WIPF1. Those networks with significant enrichment of WIPF1 genes were further investigated for enrichment of Gene Ontology categories. The significance of enrichment of either user supplied gene lists (like the gene list of the WIPF1 signature) or genes lists associated with Gene Ontology (GO) terms in gene lists of literature subnetworks is given by hypergeometric p values (with the complete set of human genes with literature information as a reference set).
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
Discovery and validation of a WIPF1 coexpression module
###end title 25
###begin p 26
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 415 416 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 650 651 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 933 934 933 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 968 969 968 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1184 1185 1184 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1268 1269 1268 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1586 1592 1586 1592 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1651 1652 1651 1652 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1693 1694 1693 1694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1839 1840 1839 1840 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1885 1886 1885 1886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2140 2141 2140 2141 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1592 2488 1592 2488 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="27">Discovery and validation of the WIPF1 coexpression module. <bold>a</bold> The histogram shows the distribution of <italic>p</italic> values resulting from tests for correlation of the WIPF1 expression profile with expression profiles of each other gene in the Aronow data set. <bold>b</bold> The histogram shows the distribution of 430 <italic>p</italic> values resulting from correlation of expression profiles in the Ayers data set of the WIPF1 gene with each discovered gene in the Aronow data set. Note the strong deviation from the uniform distribution, indicating a high rate of successful validation. <bold>c</bold> A scatter plot of the correlation coefficients in Aronow and Ayers data of each of the 112 successfully validated genes reveals that most validated genes are positively correlated with the WIPF1 profile and only six genes are anti-correlated with WIPF1. All correlation coefficients are consistent in both data sets, i.e., they have the same sign</p>
###xml 1592 2488 1592 2488 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="27">Discovery and validation of the WIPF1 coexpression module. <bold>a</bold> The histogram shows the distribution of <italic>p</italic> values resulting from tests for correlation of the WIPF1 expression profile with expression profiles of each other gene in the Aronow data set. <bold>b</bold> The histogram shows the distribution of 430 <italic>p</italic> values resulting from correlation of expression profiles in the Ayers data set of the WIPF1 gene with each discovered gene in the Aronow data set. Note the strong deviation from the uniform distribution, indicating a high rate of successful validation. <bold>c</bold> A scatter plot of the correlation coefficients in Aronow and Ayers data of each of the 112 successfully validated genes reveals that most validated genes are positively correlated with the WIPF1 profile and only six genes are anti-correlated with WIPF1. All correlation coefficients are consistent in both data sets, i.e., they have the same sign</p></caption>
###xml 2488 2488 2488 2488 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="109_2009_467_Fig1_HTML" id="MO1"/>
###xml 1586 2488 1586 2488 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="27">Discovery and validation of the WIPF1 coexpression module. <bold>a</bold> The histogram shows the distribution of <italic>p</italic> values resulting from tests for correlation of the WIPF1 expression profile with expression profiles of each other gene in the Aronow data set. <bold>b</bold> The histogram shows the distribution of 430 <italic>p</italic> values resulting from correlation of expression profiles in the Ayers data set of the WIPF1 gene with each discovered gene in the Aronow data set. Note the strong deviation from the uniform distribution, indicating a high rate of successful validation. <bold>c</bold> A scatter plot of the correlation coefficients in Aronow and Ayers data of each of the 112 successfully validated genes reveals that most validated genes are positively correlated with the WIPF1 profile and only six genes are anti-correlated with WIPF1. All correlation coefficients are consistent in both data sets, i.e., they have the same sign</p></caption><graphic position="anchor" xlink:href="109_2009_467_Fig1_HTML" id="MO1"/></fig>
We used microarray data from a study of 100 colorectal cancer specimens of mixed stage and subtype by Kaiser et al. for the identification of WIPF1 correlated genes (Gene Expression Omnibus (GEO) database identifier GSE5206) [17]. We correlated the expression profiles of the WIPF1 gene across all experiments to the expression profiles of each other gene that passed initial quality criteria. A histogram of these p values is shown in Fig. 1a. The strong deviation from a uniform distribution suggests that a large number of genes are correlated with WIPF1 expression in this data set. A threshold for significantly correlated expression was set at p < 1e-6 resulting in 430 candidate genes. For validation of the WIPF1 coexpression of these genes, we employed a data set of Ayers et al. (GSE7208) on 59 colorectal tumors [20]. We correlated the expression patterns of the 430 discovered genes to the WIPF1 profile. This led to the p value distribution shown in Fig. 1b that exhibits an even stronger deviation from the uniform distribution than for the discovery gene set, thus documenting the enrichment of true WIPF1 coexpressed genes. Genes, 112 out of 430, were correlated with p < 1e-5. A scatter plot of correlation coefficients in Ayers and Aronow data (Fig. 1c) confirmed that for all 112 genes, the correlation coefficients have the same sign, meaning that expression changes in the data sets have the same direction. In the following, these 112 genes were considered as the WIPF1 coexpression module, and their associated expression profiles constitute the WIPF1 signature. Fig. 1Discovery and validation of the WIPF1 coexpression module. a The histogram shows the distribution of p values resulting from tests for correlation of the WIPF1 expression profile with expression profiles of each other gene in the Aronow data set. b The histogram shows the distribution of 430 p values resulting from correlation of expression profiles in the Ayers data set of the WIPF1 gene with each discovered gene in the Aronow data set. Note the strong deviation from the uniform distribution, indicating a high rate of successful validation. c A scatter plot of the correlation coefficients in Aronow and Ayers data of each of the 112 successfully validated genes reveals that most validated genes are positively correlated with the WIPF1 profile and only six genes are anti-correlated with WIPF1. All correlation coefficients are consistent in both data sets, i.e., they have the same sign
###end p 26
###begin p 27
###xml 59 60 59 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 247 248 247 248 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 293 294 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 548 549 548 549 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
Discovery and validation of the WIPF1 coexpression module. a The histogram shows the distribution of p values resulting from tests for correlation of the WIPF1 expression profile with expression profiles of each other gene in the Aronow data set. b The histogram shows the distribution of 430 p values resulting from correlation of expression profiles in the Ayers data set of the WIPF1 gene with each discovered gene in the Aronow data set. Note the strong deviation from the uniform distribution, indicating a high rate of successful validation. c A scatter plot of the correlation coefficients in Aronow and Ayers data of each of the 112 successfully validated genes reveals that most validated genes are positively correlated with the WIPF1 profile and only six genes are anti-correlated with WIPF1. All correlation coefficients are consistent in both data sets, i.e., they have the same sign
###end p 27
###begin title 28
Prediction of low-risk colorectal cancers using the WIPF1 signature
###end title 28
###begin p 29
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 628 629 628 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 659 660 659 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 739 745 739 745 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 950 953 950 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Top</italic>
###xml 1018 1028 1018 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Light gray</italic>
###xml 1055 1064 1055 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dark gray</italic>
###xml 1185 1188 1185 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 1231 1235 1231 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Left</italic>
###xml 1374 1377 1374 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 1404 1409 1404 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black</italic>
###xml 745 1569 745 1569 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30">Two-way hierarchical clustering of colorectal cancer expression data from WIPF1-coexpressed genes. The data set results from fusing the Aronow and Ayers data sets and comprises 112 genes and 159 patients. <italic>Top</italic>: The dendrogram results from hierarchical clustering of tumors. <italic>Light gray</italic> indicates low expression, <italic>dark gray</italic> indicates high expression (log-transformed mean-centered). Five clusters of tumors are evident: cluster A is colored in <italic>red</italic>, all other clusters are colored in black. <italic>Left</italic>: The dendrogram results from hierarchical clustering of genes. Two main clusters of genes are evident: the larger cluster X is colored in <italic>red</italic>, the smaller cluster Y in <italic>black</italic>. Note the characteristic down-regulation of genes from cluster X in tumors from cluster A. Other tumors have anti-correlated or indifferent expression profiles</p>
###xml 745 1569 745 1569 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="30">Two-way hierarchical clustering of colorectal cancer expression data from WIPF1-coexpressed genes. The data set results from fusing the Aronow and Ayers data sets and comprises 112 genes and 159 patients. <italic>Top</italic>: The dendrogram results from hierarchical clustering of tumors. <italic>Light gray</italic> indicates low expression, <italic>dark gray</italic> indicates high expression (log-transformed mean-centered). Five clusters of tumors are evident: cluster A is colored in <italic>red</italic>, all other clusters are colored in black. <italic>Left</italic>: The dendrogram results from hierarchical clustering of genes. Two main clusters of genes are evident: the larger cluster X is colored in <italic>red</italic>, the smaller cluster Y in <italic>black</italic>. Note the characteristic down-regulation of genes from cluster X in tumors from cluster A. Other tumors have anti-correlated or indifferent expression profiles</p></caption>
###xml 1569 1569 1569 1569 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="109_2009_467_Fig2_HTML" id="MO2"/>
###xml 739 1569 739 1569 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="30">Two-way hierarchical clustering of colorectal cancer expression data from WIPF1-coexpressed genes. The data set results from fusing the Aronow and Ayers data sets and comprises 112 genes and 159 patients. <italic>Top</italic>: The dendrogram results from hierarchical clustering of tumors. <italic>Light gray</italic> indicates low expression, <italic>dark gray</italic> indicates high expression (log-transformed mean-centered). Five clusters of tumors are evident: cluster A is colored in <italic>red</italic>, all other clusters are colored in black. <italic>Left</italic>: The dendrogram results from hierarchical clustering of genes. Two main clusters of genes are evident: the larger cluster X is colored in <italic>red</italic>, the smaller cluster Y in <italic>black</italic>. Note the characteristic down-regulation of genes from cluster X in tumors from cluster A. Other tumors have anti-correlated or indifferent expression profiles</p></caption><graphic position="anchor" xlink:href="109_2009_467_Fig2_HTML" id="MO2"/></fig>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 182 190 <span type="species:ncbi:9606">patients</span>
###xml 272 280 <span type="species:ncbi:9606">patients</span>
###xml 282 289 <span type="species:ncbi:9606">Patient</span>
###xml 566 573 <span type="species:ncbi:9606">patient</span>
###xml 940 948 <span type="species:ncbi:9606">patients</span>
We fused the discovery and validation data of the WIPF1 module resulting in a data set with 112 genes and 159 patients. Then, we performed hierarchical clustering on both, genes and patients (see Fig. 2). It revealed two major clusters of genes and five major clusters of patients. Patient cluster "A" (Fig. 2, marked in red) comprises 25 tumors that exhibit a characteristic down-regulation of the larger gene cluster. In contrast, other tumor clusters (collectively labeled as "B") show an up-regulation of the larger gene cluster or indifferent expression. Using patient cluster labels as the prediction target, we trained a k-nearest neighbor classifier (k = 9) for prediction of WIPF1 cluster labels in further independent data sets. Fig. 2Two-way hierarchical clustering of colorectal cancer expression data from WIPF1-coexpressed genes. The data set results from fusing the Aronow and Ayers data sets and comprises 112 genes and 159 patients. Top: The dendrogram results from hierarchical clustering of tumors. Light gray indicates low expression, dark gray indicates high expression (log-transformed mean-centered). Five clusters of tumors are evident: cluster A is colored in red, all other clusters are colored in black. Left: The dendrogram results from hierarchical clustering of genes. Two main clusters of genes are evident: the larger cluster X is colored in red, the smaller cluster Y in black. Note the characteristic down-regulation of genes from cluster X in tumors from cluster A. Other tumors have anti-correlated or indifferent expression profiles
###end p 29
###begin p 30
###xml 205 208 205 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Top</italic>
###xml 273 283 273 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Light gray</italic>
###xml 310 319 310 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dark gray</italic>
###xml 440 443 440 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 486 490 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Left</italic>
###xml 629 632 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 659 664 659 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black</italic>
###xml 195 203 <span type="species:ncbi:9606">patients</span>
Two-way hierarchical clustering of colorectal cancer expression data from WIPF1-coexpressed genes. The data set results from fusing the Aronow and Ayers data sets and comprises 112 genes and 159 patients. Top: The dendrogram results from hierarchical clustering of tumors. Light gray indicates low expression, dark gray indicates high expression (log-transformed mean-centered). Five clusters of tumors are evident: cluster A is colored in red, all other clusters are colored in black. Left: The dendrogram results from hierarchical clustering of genes. Two main clusters of genes are evident: the larger cluster X is colored in red, the smaller cluster Y in black. Note the characteristic down-regulation of genes from cluster X in tumors from cluster A. Other tumors have anti-correlated or indifferent expression profiles
###end p 30
###begin p 31
###xml 297 298 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 613 614 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 677 698 677 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Sec2" ref-type="sec">Materials and methods</xref>
###xml 801 802 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 1003 1004 1003 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1282 1288 1282 1288 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 1713 1714 1713 1714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1288 1742 1288 1742 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32">Differences in survival between colorectal cancer patients of the &#8220;cluster B&#8221; type in an independent microarray data set. Tumors that resembled the cluster &#8220;A&#8221; type were predicted by machine learning in an independent data set of 62 tumors with microarray expression profiles. Nine cluster &#8220;A&#8221;-like patients all survived until the study end. The difference in survival compared with 53 remaining patients is significant with <italic>p</italic>&#8201;=&#8201;0.011 in the logrank test</p>
###xml 1288 1742 1288 1742 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32">Differences in survival between colorectal cancer patients of the &#8220;cluster B&#8221; type in an independent microarray data set. Tumors that resembled the cluster &#8220;A&#8221; type were predicted by machine learning in an independent data set of 62 tumors with microarray expression profiles. Nine cluster &#8220;A&#8221;-like patients all survived until the study end. The difference in survival compared with 53 remaining patients is significant with <italic>p</italic>&#8201;=&#8201;0.011 in the logrank test</p></caption>
###xml 1742 1742 1742 1742 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="109_2009_467_Fig3_HTML" id="MO3"/>
###xml 1282 1742 1282 1742 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="32">Differences in survival between colorectal cancer patients of the &#8220;cluster B&#8221; type in an independent microarray data set. Tumors that resembled the cluster &#8220;A&#8221; type were predicted by machine learning in an independent data set of 62 tumors with microarray expression profiles. Nine cluster &#8220;A&#8221;-like patients all survived until the study end. The difference in survival compared with 53 remaining patients is significant with <italic>p</italic>&#8201;=&#8201;0.011 in the logrank test</p></caption><graphic position="anchor" xlink:href="109_2009_467_Fig3_HTML" id="MO3"/></fig>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
###xml 479 487 <span type="species:ncbi:9606">patients</span>
###xml 531 539 <span type="species:ncbi:9606">patients</span>
###xml 858 866 <span type="species:ncbi:9606">patients</span>
###xml 1039 1047 <span type="species:ncbi:9606">patients</span>
###xml 1338 1346 <span type="species:ncbi:9606">patients</span>
###xml 1587 1595 <span type="species:ncbi:9606">patients</span>
###xml 1684 1692 <span type="species:ncbi:9606">patients</span>
We were interested in the question whether the cluster labels can predict certain clinical parameters in an independent colorectal cancer data set. We determined expression profiles for 62 colorectal cancer patients for which information about survival has been tracked. Direct application of the k-nearest neighbor classifier (trained on gene-wise mean-centered combined Aronow/Ayers data) on the 62 tumor expression profiles led to the assignment of cluster label "A" for nine patients and cluster label "B" for the remaining 53 patients (for a more detailed explanation/justification of the application of the k-nearest neighbor classifier across data sets we refer to the "Materials and methods" section). We compared the survival expectancy of the three groups using Kaplan-Meier plots (see Fig. 3). We found that all nine cluster "A" colorectal cancer patients have survived until the end of the study. The differences in the survival curves between clusters "A" and "B" were already significant (p = 0.011), although the numbers of patients are rather small. These results suggest that the WIPF1 expression module in combination with the applied scheme of normalization/classification also has potential for the prediction of low-risk cancers in further independent studies. Fig. 3Differences in survival between colorectal cancer patients of the "cluster B" type in an independent microarray data set. Tumors that resembled the cluster "A" type were predicted by machine learning in an independent data set of 62 tumors with microarray expression profiles. Nine cluster "A"-like patients all survived until the study end. The difference in survival compared with 53 remaining patients is significant with p = 0.011 in the logrank test
###end p 31
###begin p 32
###xml 425 426 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 50 58 <span type="species:ncbi:9606">patients</span>
###xml 299 307 <span type="species:ncbi:9606">patients</span>
###xml 396 404 <span type="species:ncbi:9606">patients</span>
Differences in survival between colorectal cancer patients of the "cluster B" type in an independent microarray data set. Tumors that resembled the cluster "A" type were predicted by machine learning in an independent data set of 62 tumors with microarray expression profiles. Nine cluster "A"-like patients all survived until the study end. The difference in survival compared with 53 remaining patients is significant with p = 0.011 in the logrank test
###end p 32
###begin title 33
The WIPF1 signature has prognostic predictivity for brain and breast tumors
###end title 33
###begin p 34
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 673 680 673 680 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 680 796 680 796 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">Summary of WIPF1 correlation and survival/relapse association for 38 core genes of the WIPF1 module and WIPF1 itself</p>
###xml 680 796 680 796 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35">Summary of WIPF1 correlation and survival/relapse association for 38 core genes of the WIPF1 module and WIPF1 itself</p></caption>
###xml 796 800 796 800 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="3">Gene</th>
###xml 800 817 800 817 <th xmlns:xlink="http://www.w3.org/1999/xlink">WIPF1 correlation</th>
###xml 817 834 817 834 <th xmlns:xlink="http://www.w3.org/1999/xlink">WIPF1 correlation</th>
###xml 834 851 834 851 <th xmlns:xlink="http://www.w3.org/1999/xlink">WIPF1 correlation</th>
###xml 851 875 851 875 <th xmlns:xlink="http://www.w3.org/1999/xlink">Cox regression Wald test</th>
###xml 875 899 875 899 <th xmlns:xlink="http://www.w3.org/1999/xlink">Cox regression Wald test</th>
###xml 796 899 796 899 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="3">Gene</th><th>WIPF1 correlation</th><th>WIPF1 correlation</th><th>WIPF1 correlation</th><th>Cox regression Wald test</th><th>Cox regression Wald test</th></tr>
###xml 899 900 899 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 899 906 899 906 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic> Value</th>
###xml 906 907 906 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 906 913 906 913 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic> Value</th>
###xml 913 914 913 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 913 920 913 920 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic> Value</th>
###xml 920 921 920 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 920 927 920 927 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic> Value</th>
###xml 927 928 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 927 934 927 934 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic> Value</th>
###xml 899 934 899 934 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th></tr>
###xml 934 945 934 945 <th xmlns:xlink="http://www.w3.org/1999/xlink">Aronow data</th>
###xml 945 955 945 955 <th xmlns:xlink="http://www.w3.org/1999/xlink">Ayers data</th>
###xml 955 965 955 965 <th xmlns:xlink="http://www.w3.org/1999/xlink">Staub data</th>
###xml 965 974 965 974 <th xmlns:xlink="http://www.w3.org/1999/xlink">Wang data</th>
###xml 974 987 974 987 <th xmlns:xlink="http://www.w3.org/1999/xlink">Phillips data</th>
###xml 934 987 934 987 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>Aronow data</th><th>Ayers data</th><th>Staub data</th><th>Wang data</th><th>Phillips data</th></tr>
###xml 796 987 796 987 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="3">Gene</th><th>WIPF1 correlation</th><th>WIPF1 correlation</th><th>WIPF1 correlation</th><th>Cox regression Wald test</th><th>Cox regression Wald test</th></tr><tr><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th></tr><tr><th>Aronow data</th><th>Ayers data</th><th>Staub data</th><th>Wang data</th><th>Phillips data</th></tr></thead>
###xml 987 992 987 992 <td xmlns:xlink="http://www.w3.org/1999/xlink">AGGF1</td>
###xml 992 1000 992 1000 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.01E&#8722;09</td>
###xml 1000 1008 1000 1008 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.40E&#8722;06</td>
###xml 1008 1016 1008 1016 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.66E&#8722;03</td>
###xml 1016 1024 1016 1024 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.74E&#8722;01</td>
###xml 1024 1032 1024 1032 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.74E&#8722;01</td>
###xml 987 1032 987 1032 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>AGGF1</td><td>1.01E&#8722;09</td><td>6.40E&#8722;06</td><td>6.66E&#8722;03</td><td char="." align="char">4.74E&#8722;01</td><td char="." align="char">7.74E&#8722;01</td></tr>
###xml 1032 1036 1032 1036 <td xmlns:xlink="http://www.w3.org/1999/xlink">AVEN</td>
###xml 1036 1044 1036 1044 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.87E&#8722;10</td>
###xml 1044 1052 1044 1052 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.04E&#8722;08</td>
###xml 1052 1060 1052 1060 <td xmlns:xlink="http://www.w3.org/1999/xlink">9.21E&#8722;08</td>
###xml 1060 1068 1060 1068 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.23E&#8722;04</td>
###xml 1068 1076 1068 1076 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6.37E&#8722;04</td>
###xml 1032 1076 1032 1076 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>AVEN</td><td>1.87E&#8722;10</td><td>1.04E&#8722;08</td><td>9.21E&#8722;08</td><td char="." align="char">1.23E&#8722;04</td><td char="." align="char">6.37E&#8722;04</td></tr>
###xml 1076 1079 1076 1079 <td xmlns:xlink="http://www.w3.org/1999/xlink">AXL</td>
###xml 1079 1087 1079 1087 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.15E-07</td>
###xml 1087 1095 1087 1095 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.18E-06</td>
###xml 1095 1103 1095 1103 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.27E-04</td>
###xml 1103 1111 1103 1111 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">9.10E-02</td>
###xml 1111 1119 1111 1119 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.23E-05</td>
###xml 1076 1119 1076 1119 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>AXL</td><td>3.15E-07</td><td>4.18E-06</td><td>1.27E-04</td><td char="." align="char">9.10E-02</td><td char="." align="char">2.23E-05</td></tr>
###xml 1119 1123 1119 1123 <td xmlns:xlink="http://www.w3.org/1999/xlink">BIN1</td>
###xml 1123 1131 1123 1131 <td xmlns:xlink="http://www.w3.org/1999/xlink">9.45E-08</td>
###xml 1131 1139 1131 1139 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.09E-08</td>
###xml 1139 1147 1139 1147 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.57E-04</td>
###xml 1147 1155 1147 1155 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8.26E-02</td>
###xml 1155 1163 1155 1163 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.01E-02</td>
###xml 1119 1163 1119 1163 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>BIN1</td><td>9.45E-08</td><td>4.09E-08</td><td>1.57E-04</td><td char="." align="char">8.26E-02</td><td char="." align="char">1.01E-02</td></tr>
###xml 1163 1171 1163 1171 <td xmlns:xlink="http://www.w3.org/1999/xlink">C12orf29</td>
###xml 1171 1179 1171 1179 <td xmlns:xlink="http://www.w3.org/1999/xlink">9.28E-07</td>
###xml 1179 1187 1179 1187 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.99E-07</td>
###xml 1187 1195 1187 1195 <td xmlns:xlink="http://www.w3.org/1999/xlink">9.31E-04</td>
###xml 1195 1203 1195 1203 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.75E-02</td>
###xml 1203 1211 1203 1211 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.31E-06</td>
###xml 1163 1211 1163 1211 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>C12orf29</td><td>9.28E-07</td><td>4.99E-07</td><td>9.31E-04</td><td char="." align="char">4.75E-02</td><td char="." align="char">7.31E-06</td></tr>
###xml 1211 1219 1211 1219 <td xmlns:xlink="http://www.w3.org/1999/xlink">C12orf43</td>
###xml 1219 1227 1219 1227 <td xmlns:xlink="http://www.w3.org/1999/xlink">9.05E-12</td>
###xml 1227 1235 1227 1235 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.61E-09</td>
###xml 1235 1243 1235 1243 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.27E-03</td>
###xml 1243 1251 1243 1251 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.46E-02</td>
###xml 1251 1259 1251 1259 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.35E-04</td>
###xml 1211 1259 1211 1259 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>C12orf43</td><td>9.05E-12</td><td>1.61E-09</td><td>3.27E-03</td><td char="." align="char">2.46E-02</td><td char="." align="char">1.35E-04</td></tr>
###xml 1259 1263 1259 1263 <td xmlns:xlink="http://www.w3.org/1999/xlink">C1QB</td>
###xml 1263 1271 1263 1271 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.44E-16</td>
###xml 1271 1279 1271 1279 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.73E-07</td>
###xml 1279 1287 1279 1287 <td xmlns:xlink="http://www.w3.org/1999/xlink">9.96E&#8722;04</td>
###xml 1287 1295 1287 1295 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.76E&#8722;02</td>
###xml 1295 1303 1295 1303 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.56E&#8722;02</td>
###xml 1259 1303 1259 1303 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>C1QB</td><td>4.44E-16</td><td>6.73E-07</td><td>9.96E&#8722;04</td><td char="." align="char">1.76E&#8722;02</td><td char="." align="char">1.56E&#8722;02</td></tr>
###xml 1303 1308 1303 1308 <td xmlns:xlink="http://www.w3.org/1999/xlink">CCL16</td>
###xml 1308 1316 1308 1316 <td xmlns:xlink="http://www.w3.org/1999/xlink">8.44E&#8722;15</td>
###xml 1316 1324 1316 1324 <td xmlns:xlink="http://www.w3.org/1999/xlink">9.04E&#8722;10</td>
###xml 1324 1332 1324 1332 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.02E-04</td>
###xml 1332 1340 1332 1340 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.16E&#8722;03</td>
###xml 1340 1348 1340 1348 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">9.65E&#8722;04</td>
###xml 1303 1348 1303 1348 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>CCL16</td><td>8.44E&#8722;15</td><td>9.04E&#8722;10</td><td>3.02E-04</td><td char="." align="char">4.16E&#8722;03</td><td char="." align="char">9.65E&#8722;04</td></tr>
###xml 1348 1354 1348 1354 <td xmlns:xlink="http://www.w3.org/1999/xlink">CHRDL1</td>
###xml 1354 1362 1354 1362 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.22E&#8722;09</td>
###xml 1362 1370 1362 1370 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.17E&#8722;07</td>
###xml 1370 1378 1370 1378 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.10E&#8722;03</td>
###xml 1378 1386 1378 1386 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.34E&#8722;03</td>
###xml 1386 1394 1386 1394 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5.83E&#8722;03</td>
###xml 1348 1394 1348 1394 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>CHRDL1</td><td>1.22E&#8722;09</td><td>1.17E&#8722;07</td><td>2.10E&#8722;03</td><td char="." align="char">1.34E&#8722;03</td><td char="." align="char">5.83E&#8722;03</td></tr>
###xml 1394 1399 1394 1399 <td xmlns:xlink="http://www.w3.org/1999/xlink">CYLC1</td>
###xml 1399 1407 1399 1407 <td xmlns:xlink="http://www.w3.org/1999/xlink">9.27E&#8722;12</td>
###xml 1407 1415 1407 1415 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.91E&#8722;06</td>
###xml 1415 1423 1415 1423 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.33E&#8722;04</td>
###xml 1423 1431 1423 1431 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.16E&#8722;03</td>
###xml 1431 1439 1431 1439 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.38E&#8722;01</td>
###xml 1394 1439 1394 1439 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>CYLC1</td><td>9.27E&#8722;12</td><td>1.91E&#8722;06</td><td>5.33E&#8722;04</td><td char="." align="char">1.16E&#8722;03</td><td char="." align="char">2.38E&#8722;01</td></tr>
###xml 1439 1444 1439 1444 <td xmlns:xlink="http://www.w3.org/1999/xlink">DDX50</td>
###xml 1444 1452 1444 1452 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.69E&#8722;07</td>
###xml 1452 1460 1452 1460 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.60E&#8722;09</td>
###xml 1460 1468 1460 1468 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.35E&#8722;08</td>
###xml 1468 1476 1468 1476 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5.63E&#8722;04</td>
###xml 1476 1484 1476 1484 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.08E&#8722;03</td>
###xml 1439 1484 1439 1484 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>DDX50</td><td>3.69E&#8722;07</td><td>3.60E&#8722;09</td><td>1.35E&#8722;08</td><td char="." align="char">5.63E&#8722;04</td><td char="." align="char">7.08E&#8722;03</td></tr>
###xml 1484 1489 1484 1489 <td xmlns:xlink="http://www.w3.org/1999/xlink">DECR2</td>
###xml 1489 1497 1489 1497 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.89E&#8722;12</td>
###xml 1497 1505 1497 1505 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.55E&#8722;07</td>
###xml 1505 1513 1505 1513 <td xmlns:xlink="http://www.w3.org/1999/xlink">8.30E&#8722;07</td>
###xml 1513 1521 1513 1521 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8.97E&#8722;04</td>
###xml 1521 1529 1521 1529 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.46E&#8722;04</td>
###xml 1484 1529 1484 1529 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>DECR2</td><td>4.89E&#8722;12</td><td>4.55E&#8722;07</td><td>8.30E&#8722;07</td><td char="." align="char">8.97E&#8722;04</td><td char="." align="char">1.46E&#8722;04</td></tr>
###xml 1529 1533 1529 1533 <td xmlns:xlink="http://www.w3.org/1999/xlink">DEDD</td>
###xml 1533 1541 1533 1541 <td xmlns:xlink="http://www.w3.org/1999/xlink">7.73E&#8722;12</td>
###xml 1541 1549 1541 1549 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.91E&#8722;08</td>
###xml 1549 1557 1549 1557 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.10E&#8722;11</td>
###xml 1557 1565 1557 1565 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.48E&#8722;03</td>
###xml 1565 1573 1565 1573 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.74E&#8722;02</td>
###xml 1529 1573 1529 1573 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>DEDD</td><td>7.73E&#8722;12</td><td>4.91E&#8722;08</td><td>6.10E&#8722;11</td><td char="." align="char">1.48E&#8722;03</td><td char="." align="char">2.74E&#8722;02</td></tr>
###xml 1573 1577 1573 1577 <td xmlns:xlink="http://www.w3.org/1999/xlink">DTX4</td>
###xml 1577 1585 1577 1585 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.00E&#8722;09</td>
###xml 1585 1593 1585 1593 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.28E&#8722;07</td>
###xml 1593 1601 1593 1601 <td xmlns:xlink="http://www.w3.org/1999/xlink">7.26E&#8722;04</td>
###xml 1601 1609 1601 1609 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.73E&#8722;01</td>
###xml 1609 1617 1609 1617 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5.25E&#8722;05</td>
###xml 1573 1617 1573 1617 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>DTX4</td><td>4.00E&#8722;09</td><td>3.28E&#8722;07</td><td>7.26E&#8722;04</td><td char="." align="char">7.73E&#8722;01</td><td char="." align="char">5.25E&#8722;05</td></tr>
###xml 1617 1622 1617 1622 <td xmlns:xlink="http://www.w3.org/1999/xlink">EFHD2</td>
###xml 1622 1630 1622 1630 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.97E&#8722;08</td>
###xml 1630 1638 1630 1638 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.55E&#8722;06</td>
###xml 1638 1646 1638 1646 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.42E&#8722;03</td>
###xml 1646 1654 1646 1654 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.05E&#8722;01</td>
###xml 1654 1662 1654 1662 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.42E&#8722;02</td>
###xml 1617 1662 1617 1662 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>EFHD2</td><td>3.97E&#8722;08</td><td>2.55E&#8722;06</td><td>3.42E&#8722;03</td><td char="." align="char">2.05E&#8722;01</td><td char="." align="char">2.42E&#8722;02</td></tr>
###xml 1662 1668 1662 1668 <td xmlns:xlink="http://www.w3.org/1999/xlink">GTPBP2</td>
###xml 1668 1676 1668 1676 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.64E&#8722;12</td>
###xml 1676 1684 1676 1684 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.01E&#8722;10</td>
###xml 1684 1692 1684 1692 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.26E&#8722;05</td>
###xml 1692 1700 1692 1700 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.55E&#8722;05</td>
###xml 1700 1708 1700 1708 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.63E&#8722;02</td>
###xml 1662 1708 1662 1708 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>GTPBP2</td><td>4.64E&#8722;12</td><td>3.01E&#8722;10</td><td>1.26E&#8722;05</td><td char="." align="char">1.55E&#8722;05</td><td char="." align="char">1.63E&#8722;02</td></tr>
###xml 1708 1714 1708 1714 <td xmlns:xlink="http://www.w3.org/1999/xlink">HSPA14</td>
###xml 1714 1722 1714 1722 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.18E&#8722;12</td>
###xml 1722 1730 1722 1730 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.92E-06</td>
###xml 1730 1738 1730 1738 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.84E-03</td>
###xml 1738 1746 1738 1746 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6.09E-01</td>
###xml 1746 1754 1746 1754 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6.07E-03</td>
###xml 1708 1754 1708 1754 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>HSPA14</td><td>1.18E&#8722;12</td><td>2.92E-06</td><td>1.84E-03</td><td char="." align="char">6.09E-01</td><td char="." align="char">6.07E-03</td></tr>
###xml 1754 1757 1754 1757 <td xmlns:xlink="http://www.w3.org/1999/xlink">IPW</td>
###xml 1757 1765 1757 1765 <td xmlns:xlink="http://www.w3.org/1999/xlink">9.49E-10</td>
###xml 1765 1773 1765 1773 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.44E-07</td>
###xml 1773 1781 1773 1781 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.64E-05</td>
###xml 1781 1789 1781 1789 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.38E-03</td>
###xml 1789 1797 1789 1797 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.69E-02</td>
###xml 1754 1797 1754 1797 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>IPW</td><td>9.49E-10</td><td>2.44E-07</td><td>1.64E-05</td><td char="." align="char">2.38E-03</td><td char="." align="char">3.69E-02</td></tr>
###xml 1797 1804 1797 1804 <td xmlns:xlink="http://www.w3.org/1999/xlink">MADCAM1</td>
###xml 1804 1812 1804 1812 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.39E-08</td>
###xml 1812 1820 1812 1820 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.19E-06</td>
###xml 1820 1828 1820 1828 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.16E-03</td>
###xml 1828 1836 1828 1836 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.89E-01</td>
###xml 1836 1844 1836 1844 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.22E-02</td>
###xml 1797 1844 1797 1844 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>MADCAM1</td><td>1.39E-08</td><td>2.19E-06</td><td>1.16E-03</td><td char="." align="char">3.89E-01</td><td char="." align="char">1.22E-02</td></tr>
###xml 1844 1848 1844 1848 <td xmlns:xlink="http://www.w3.org/1999/xlink">MINA</td>
###xml 1848 1856 1848 1856 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00E+00</td>
###xml 1856 1864 1856 1864 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.98E-06</td>
###xml 1864 1872 1864 1872 <td xmlns:xlink="http://www.w3.org/1999/xlink">8.23E-05</td>
###xml 1872 1880 1872 1880 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">9.65E-02</td>
###xml 1880 1888 1880 1888 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5.60E-03</td>
###xml 1844 1888 1844 1888 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>MINA</td><td>0.00E+00</td><td>6.98E-06</td><td>8.23E-05</td><td char="." align="char">9.65E-02</td><td char="." align="char">5.60E-03</td></tr>
###xml 1888 1895 1888 1895 <td xmlns:xlink="http://www.w3.org/1999/xlink">MOBKL2B</td>
###xml 1895 1903 1895 1903 <td xmlns:xlink="http://www.w3.org/1999/xlink">8.13E-12</td>
###xml 1903 1911 1903 1911 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.70E-06</td>
###xml 1911 1919 1911 1919 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.86E-03</td>
###xml 1919 1927 1919 1927 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.61E&#8722;01</td>
###xml 1927 1935 1927 1935 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">9.03E&#8722;01</td>
###xml 1888 1935 1888 1935 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>MOBKL2B</td><td>8.13E-12</td><td>4.70E-06</td><td>5.86E-03</td><td char="." align="char">1.61E&#8722;01</td><td char="." align="char">9.03E&#8722;01</td></tr>
###xml 1935 1941 1935 1941 <td xmlns:xlink="http://www.w3.org/1999/xlink">MRPL16</td>
###xml 1941 1949 1941 1949 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.48E&#8722;09</td>
###xml 1949 1957 1949 1957 <td xmlns:xlink="http://www.w3.org/1999/xlink">9.52E&#8722;10</td>
###xml 1957 1965 1957 1965 <td xmlns:xlink="http://www.w3.org/1999/xlink">8.58E&#8722;04</td>
###xml 1965 1973 1965 1973 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.36E&#8722;01</td>
###xml 1973 1981 1973 1981 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.49E&#8722;02</td>
###xml 1935 1981 1935 1981 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>MRPL16</td><td>1.48E&#8722;09</td><td>9.52E&#8722;10</td><td>8.58E&#8722;04</td><td char="." align="char">1.36E&#8722;01</td><td char="." align="char">4.49E&#8722;02</td></tr>
###xml 1981 1987 1981 1987 <td xmlns:xlink="http://www.w3.org/1999/xlink">MS4A12</td>
###xml 1987 1995 1987 1995 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.36E&#8722;13</td>
###xml 1995 2003 1995 2003 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.77E&#8722;10</td>
###xml 2003 2011 2003 2011 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.02E&#8722;04</td>
###xml 2011 2019 2011 2019 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.64E&#8722;01</td>
###xml 2019 2027 2019 2027 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.02E&#8722;03</td>
###xml 1981 2027 1981 2027 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>MS4A12</td><td>1.36E&#8722;13</td><td>2.77E&#8722;10</td><td>2.02E&#8722;04</td><td char="." align="char">4.64E&#8722;01</td><td char="." align="char">1.02E&#8722;03</td></tr>
###xml 2027 2030 2027 2030 <td xmlns:xlink="http://www.w3.org/1999/xlink">NF1</td>
###xml 2030 2038 2030 2038 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.31E&#8722;14</td>
###xml 2038 2046 2038 2046 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.16E&#8722;07</td>
###xml 2046 2054 2046 2054 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.94E&#8722;03</td>
###xml 2054 2062 2054 2062 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.51E&#8722;01</td>
###xml 2062 2070 2062 2070 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6.15E&#8722;02</td>
###xml 2027 2070 2027 2070 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>NF1</td><td>1.31E&#8722;14</td><td>2.16E&#8722;07</td><td>6.94E&#8722;03</td><td char="." align="char">3.51E&#8722;01</td><td char="." align="char">6.15E&#8722;02</td></tr>
###xml 2070 2074 2070 2074 <td xmlns:xlink="http://www.w3.org/1999/xlink">NIP7</td>
###xml 2074 2082 2074 2082 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.92E&#8722;09</td>
###xml 2082 2090 2082 2090 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.03E&#8722;08</td>
###xml 2090 2098 2090 2098 <td xmlns:xlink="http://www.w3.org/1999/xlink">7.09E&#8722;03</td>
###xml 2098 2106 2098 2106 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.60E&#8722;01</td>
###xml 2106 2114 2106 2114 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8.45E&#8722;01</td>
###xml 2070 2114 2070 2114 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>NIP7</td><td>1.92E&#8722;09</td><td>2.03E&#8722;08</td><td>7.09E&#8722;03</td><td char="." align="char">4.60E&#8722;01</td><td char="." align="char">8.45E&#8722;01</td></tr>
###xml 2114 2117 2114 2117 <td xmlns:xlink="http://www.w3.org/1999/xlink">NLK</td>
###xml 2117 2125 2117 2125 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.00E+00</td>
###xml 2125 2133 2125 2133 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.29E&#8722;09</td>
###xml 2133 2141 2133 2141 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.99E&#8722;05</td>
###xml 2141 2149 2141 2149 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.86E&#8722;03</td>
###xml 2149 2157 2149 2157 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.52E&#8722;02</td>
###xml 2114 2157 2114 2157 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>NLK</td><td>0.00E+00</td><td>3.29E&#8722;09</td><td>6.99E&#8722;05</td><td char="." align="char">7.86E&#8722;03</td><td char="." align="char">3.52E&#8722;02</td></tr>
###xml 2157 2161 2157 2161 <td xmlns:xlink="http://www.w3.org/1999/xlink">NT5E</td>
###xml 2161 2169 2161 2169 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.61E&#8722;12</td>
###xml 2169 2177 2169 2177 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.34E&#8722;09</td>
###xml 2177 2185 2177 2185 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.05E&#8722;04</td>
###xml 2185 2193 2185 2193 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5.92E&#8722;06</td>
###xml 2193 2201 2193 2201 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.19E&#8722;03</td>
###xml 2157 2201 2157 2201 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>NT5E</td><td>3.61E&#8722;12</td><td>4.34E&#8722;09</td><td>1.05E&#8722;04</td><td char="." align="char">5.92E&#8722;06</td><td char="." align="char">4.19E&#8722;03</td></tr>
###xml 2201 2205 2201 2205 <td xmlns:xlink="http://www.w3.org/1999/xlink">PGM1</td>
###xml 2205 2213 2205 2213 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.93E&#8722;07</td>
###xml 2213 2221 2213 2221 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.17E&#8722;07</td>
###xml 2221 2229 2221 2229 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.95E&#8722;03</td>
###xml 2229 2237 2229 2237 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.04E&#8722;01</td>
###xml 2237 2245 2237 2245 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8.73E&#8722;01</td>
###xml 2201 2245 2201 2245 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>PGM1</td><td>3.93E&#8722;07</td><td>3.17E&#8722;07</td><td>4.95E&#8722;03</td><td char="." align="char">4.04E&#8722;01</td><td char="." align="char">8.73E&#8722;01</td></tr>
###xml 2245 2252 2245 2252 <td xmlns:xlink="http://www.w3.org/1999/xlink">PLA2G2E</td>
###xml 2252 2260 2252 2260 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.99E&#8722;11</td>
###xml 2260 2268 2260 2268 <td xmlns:xlink="http://www.w3.org/1999/xlink">9.69E&#8722;06</td>
###xml 2268 2276 2268 2276 <td xmlns:xlink="http://www.w3.org/1999/xlink">6.35E&#8722;04</td>
###xml 2276 2284 2276 2284 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.24E&#8722;01</td>
###xml 2284 2292 2284 2292 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.04E&#8722;03</td>
###xml 2245 2292 2245 2292 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>PLA2G2E</td><td>1.99E&#8722;11</td><td>9.69E&#8722;06</td><td>6.35E&#8722;04</td><td char="." align="char">2.24E&#8722;01</td><td char="." align="char">1.04E&#8722;03</td></tr>
###xml 2292 2298 2292 2298 <td xmlns:xlink="http://www.w3.org/1999/xlink">SCUBE2</td>
###xml 2298 2306 2298 2306 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.93E&#8722;08</td>
###xml 2306 2314 2306 2314 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.20E&#8722;06</td>
###xml 2314 2322 2314 2322 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.94E&#8722;03</td>
###xml 2322 2330 2322 2330 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.52E&#8722;04</td>
###xml 2330 2338 2330 2338 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.49E&#8722;03</td>
###xml 2292 2338 2292 2338 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>SCUBE2</td><td>4.93E&#8722;08</td><td>4.20E&#8722;06</td><td>1.94E&#8722;03</td><td char="." align="char">7.52E&#8722;04</td><td char="." align="char">2.49E&#8722;03</td></tr>
###xml 2338 2343 2338 2343 <td xmlns:xlink="http://www.w3.org/1999/xlink">SH2B1</td>
###xml 2343 2351 2343 2351 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.29E&#8722;11</td>
###xml 2351 2359 2351 2359 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.68E&#8722;08</td>
###xml 2359 2367 2359 2367 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.28E&#8722;06</td>
###xml 2367 2375 2367 2375 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5.99E&#8722;03</td>
###xml 2375 2383 2375 2383 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6.13E&#8722;03</td>
###xml 2338 2383 2338 2383 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>SH2B1</td><td>1.29E&#8722;11</td><td>2.68E&#8722;08</td><td>1.28E&#8722;06</td><td char="." align="char">5.99E&#8722;03</td><td char="." align="char">6.13E&#8722;03</td></tr>
###xml 2383 2390 2383 2390 <td xmlns:xlink="http://www.w3.org/1999/xlink">SLC24A1</td>
###xml 2390 2398 2390 2398 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.06E&#8722;09</td>
###xml 2398 2406 2398 2406 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.12E&#8722;08</td>
###xml 2406 2414 2406 2414 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.70E&#8722;03</td>
###xml 2414 2422 2414 2422 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.26E&#8722;05</td>
###xml 2422 2430 2422 2430 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.92E&#8722;04</td>
###xml 2383 2430 2383 2430 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>SLC24A1</td><td>1.06E&#8722;09</td><td>5.12E&#8722;08</td><td>4.70E&#8722;03</td><td char="." align="char">2.26E&#8722;05</td><td char="." align="char">1.92E&#8722;04</td></tr>
###xml 2430 2437 2430 2437 <td xmlns:xlink="http://www.w3.org/1999/xlink">SLC39A7</td>
###xml 2437 2445 2437 2445 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.17E&#8722;07</td>
###xml 2445 2453 2445 2453 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.49E&#8722;06</td>
###xml 2453 2461 2453 2461 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.72E&#8722;04</td>
###xml 2461 2469 2461 2469 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.57E&#8722;03</td>
###xml 2469 2477 2469 2477 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">9.01E&#8722;05</td>
###xml 2430 2477 2430 2477 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>SLC39A7</td><td>1.17E&#8722;07</td><td>4.49E&#8722;06</td><td>1.72E&#8722;04</td><td char="." align="char">3.57E&#8722;03</td><td char="." align="char">9.01E&#8722;05</td></tr>
###xml 2477 2483 2477 2483 <td xmlns:xlink="http://www.w3.org/1999/xlink">SPBC25</td>
###xml 2483 2491 2483 2491 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.28E&#8722;11</td>
###xml 2491 2499 2491 2499 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.89E&#8722;06</td>
###xml 2499 2507 2499 2507 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.90E&#8722;05</td>
###xml 2507 2515 2507 2515 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.48E&#8722;03</td>
###xml 2515 2523 2515 2523 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.39E&#8722;03</td>
###xml 2477 2523 2477 2523 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>SPBC25</td><td>1.28E&#8722;11</td><td>5.89E&#8722;06</td><td>2.90E&#8722;05</td><td char="." align="char">1.48E&#8722;03</td><td char="." align="char">2.39E&#8722;03</td></tr>
###xml 2523 2527 2523 2527 <td xmlns:xlink="http://www.w3.org/1999/xlink">THBD</td>
###xml 2527 2535 2527 2535 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.02E&#8722;14</td>
###xml 2535 2543 2535 2543 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.78E&#8722;06</td>
###xml 2543 2551 2543 2551 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.81E&#8722;03</td>
###xml 2551 2559 2551 2559 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.79E&#8722;03</td>
###xml 2559 2567 2559 2567 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8.01E&#8722;04</td>
###xml 2523 2567 2523 2567 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>THBD</td><td>1.02E&#8722;14</td><td>1.78E&#8722;06</td><td>3.81E&#8722;03</td><td char="." align="char">1.79E&#8722;03</td><td char="." align="char">8.01E&#8722;04</td></tr>
###xml 2567 2572 2567 2572 <td xmlns:xlink="http://www.w3.org/1999/xlink">TXNIP</td>
###xml 2572 2580 2572 2580 <td xmlns:xlink="http://www.w3.org/1999/xlink">8.99E&#8722;08</td>
###xml 2580 2588 2580 2588 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.85E&#8722;07</td>
###xml 2588 2596 2588 2596 <td xmlns:xlink="http://www.w3.org/1999/xlink">9.15E&#8722;04</td>
###xml 2596 2604 2596 2604 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2.85E&#8722;01</td>
###xml 2604 2612 2604 2612 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.25E&#8722;01</td>
###xml 2567 2612 2567 2612 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>TXNIP</td><td>8.99E&#8722;08</td><td>1.85E&#8722;07</td><td>9.15E&#8722;04</td><td char="." align="char">2.85E&#8722;01</td><td char="." align="char">1.25E&#8722;01</td></tr>
###xml 2612 2618 2612 2618 <td xmlns:xlink="http://www.w3.org/1999/xlink">UBE2E3</td>
###xml 2618 2626 2618 2626 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.55E&#8722;15</td>
###xml 2626 2634 2626 2634 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.31E&#8722;07</td>
###xml 2634 2642 2634 2642 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.94E&#8722;04</td>
###xml 2642 2650 2642 2650 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4.08E&#8722;04</td>
###xml 2650 2658 2650 2658 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3.28E&#8722;02</td>
###xml 2612 2658 2612 2658 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>UBE2E3</td><td>1.55E&#8722;15</td><td>1.31E&#8722;07</td><td>5.94E&#8722;04</td><td char="." align="char">4.08E&#8722;04</td><td char="." align="char">3.28E&#8722;02</td></tr>
###xml 2658 2664 2658 2664 <td xmlns:xlink="http://www.w3.org/1999/xlink">ZNF230</td>
###xml 2664 2672 2664 2672 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.60E&#8722;09</td>
###xml 2672 2680 2672 2680 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.87E&#8722;09</td>
###xml 2680 2688 2680 2688 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.90E&#8722;09</td>
###xml 2688 2696 2688 2696 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6.37E&#8722;04</td>
###xml 2696 2704 2696 2704 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.03E&#8722;03</td>
###xml 2658 2704 2658 2704 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>ZNF230</td><td>1.60E&#8722;09</td><td>3.87E&#8722;09</td><td>1.90E&#8722;09</td><td char="." align="char">6.37E&#8722;04</td><td char="." align="char">1.03E&#8722;03</td></tr>
###xml 2704 2709 2704 2709 <td xmlns:xlink="http://www.w3.org/1999/xlink">WIPF1</td>
###xml 2709 2710 2709 2710 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 2710 2711 2710 2711 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 2711 2712 2711 2712 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</td>
###xml 2712 2720 2712 2720 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6.92E&#8722;06</td>
###xml 2720 2728 2720 2728 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7.80E&#8722;02</td>
###xml 2704 2728 2704 2728 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>WIPF1</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td><td char="." align="char">6.92E&#8722;06</td><td char="." align="char">7.80E&#8722;02</td></tr>
###xml 987 2728 987 2728 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>AGGF1</td><td>1.01E&#8722;09</td><td>6.40E&#8722;06</td><td>6.66E&#8722;03</td><td char="." align="char">4.74E&#8722;01</td><td char="." align="char">7.74E&#8722;01</td></tr><tr><td>AVEN</td><td>1.87E&#8722;10</td><td>1.04E&#8722;08</td><td>9.21E&#8722;08</td><td char="." align="char">1.23E&#8722;04</td><td char="." align="char">6.37E&#8722;04</td></tr><tr><td>AXL</td><td>3.15E-07</td><td>4.18E-06</td><td>1.27E-04</td><td char="." align="char">9.10E-02</td><td char="." align="char">2.23E-05</td></tr><tr><td>BIN1</td><td>9.45E-08</td><td>4.09E-08</td><td>1.57E-04</td><td char="." align="char">8.26E-02</td><td char="." align="char">1.01E-02</td></tr><tr><td>C12orf29</td><td>9.28E-07</td><td>4.99E-07</td><td>9.31E-04</td><td char="." align="char">4.75E-02</td><td char="." align="char">7.31E-06</td></tr><tr><td>C12orf43</td><td>9.05E-12</td><td>1.61E-09</td><td>3.27E-03</td><td char="." align="char">2.46E-02</td><td char="." align="char">1.35E-04</td></tr><tr><td>C1QB</td><td>4.44E-16</td><td>6.73E-07</td><td>9.96E&#8722;04</td><td char="." align="char">1.76E&#8722;02</td><td char="." align="char">1.56E&#8722;02</td></tr><tr><td>CCL16</td><td>8.44E&#8722;15</td><td>9.04E&#8722;10</td><td>3.02E-04</td><td char="." align="char">4.16E&#8722;03</td><td char="." align="char">9.65E&#8722;04</td></tr><tr><td>CHRDL1</td><td>1.22E&#8722;09</td><td>1.17E&#8722;07</td><td>2.10E&#8722;03</td><td char="." align="char">1.34E&#8722;03</td><td char="." align="char">5.83E&#8722;03</td></tr><tr><td>CYLC1</td><td>9.27E&#8722;12</td><td>1.91E&#8722;06</td><td>5.33E&#8722;04</td><td char="." align="char">1.16E&#8722;03</td><td char="." align="char">2.38E&#8722;01</td></tr><tr><td>DDX50</td><td>3.69E&#8722;07</td><td>3.60E&#8722;09</td><td>1.35E&#8722;08</td><td char="." align="char">5.63E&#8722;04</td><td char="." align="char">7.08E&#8722;03</td></tr><tr><td>DECR2</td><td>4.89E&#8722;12</td><td>4.55E&#8722;07</td><td>8.30E&#8722;07</td><td char="." align="char">8.97E&#8722;04</td><td char="." align="char">1.46E&#8722;04</td></tr><tr><td>DEDD</td><td>7.73E&#8722;12</td><td>4.91E&#8722;08</td><td>6.10E&#8722;11</td><td char="." align="char">1.48E&#8722;03</td><td char="." align="char">2.74E&#8722;02</td></tr><tr><td>DTX4</td><td>4.00E&#8722;09</td><td>3.28E&#8722;07</td><td>7.26E&#8722;04</td><td char="." align="char">7.73E&#8722;01</td><td char="." align="char">5.25E&#8722;05</td></tr><tr><td>EFHD2</td><td>3.97E&#8722;08</td><td>2.55E&#8722;06</td><td>3.42E&#8722;03</td><td char="." align="char">2.05E&#8722;01</td><td char="." align="char">2.42E&#8722;02</td></tr><tr><td>GTPBP2</td><td>4.64E&#8722;12</td><td>3.01E&#8722;10</td><td>1.26E&#8722;05</td><td char="." align="char">1.55E&#8722;05</td><td char="." align="char">1.63E&#8722;02</td></tr><tr><td>HSPA14</td><td>1.18E&#8722;12</td><td>2.92E-06</td><td>1.84E-03</td><td char="." align="char">6.09E-01</td><td char="." align="char">6.07E-03</td></tr><tr><td>IPW</td><td>9.49E-10</td><td>2.44E-07</td><td>1.64E-05</td><td char="." align="char">2.38E-03</td><td char="." align="char">3.69E-02</td></tr><tr><td>MADCAM1</td><td>1.39E-08</td><td>2.19E-06</td><td>1.16E-03</td><td char="." align="char">3.89E-01</td><td char="." align="char">1.22E-02</td></tr><tr><td>MINA</td><td>0.00E+00</td><td>6.98E-06</td><td>8.23E-05</td><td char="." align="char">9.65E-02</td><td char="." align="char">5.60E-03</td></tr><tr><td>MOBKL2B</td><td>8.13E-12</td><td>4.70E-06</td><td>5.86E-03</td><td char="." align="char">1.61E&#8722;01</td><td char="." align="char">9.03E&#8722;01</td></tr><tr><td>MRPL16</td><td>1.48E&#8722;09</td><td>9.52E&#8722;10</td><td>8.58E&#8722;04</td><td char="." align="char">1.36E&#8722;01</td><td char="." align="char">4.49E&#8722;02</td></tr><tr><td>MS4A12</td><td>1.36E&#8722;13</td><td>2.77E&#8722;10</td><td>2.02E&#8722;04</td><td char="." align="char">4.64E&#8722;01</td><td char="." align="char">1.02E&#8722;03</td></tr><tr><td>NF1</td><td>1.31E&#8722;14</td><td>2.16E&#8722;07</td><td>6.94E&#8722;03</td><td char="." align="char">3.51E&#8722;01</td><td char="." align="char">6.15E&#8722;02</td></tr><tr><td>NIP7</td><td>1.92E&#8722;09</td><td>2.03E&#8722;08</td><td>7.09E&#8722;03</td><td char="." align="char">4.60E&#8722;01</td><td char="." align="char">8.45E&#8722;01</td></tr><tr><td>NLK</td><td>0.00E+00</td><td>3.29E&#8722;09</td><td>6.99E&#8722;05</td><td char="." align="char">7.86E&#8722;03</td><td char="." align="char">3.52E&#8722;02</td></tr><tr><td>NT5E</td><td>3.61E&#8722;12</td><td>4.34E&#8722;09</td><td>1.05E&#8722;04</td><td char="." align="char">5.92E&#8722;06</td><td char="." align="char">4.19E&#8722;03</td></tr><tr><td>PGM1</td><td>3.93E&#8722;07</td><td>3.17E&#8722;07</td><td>4.95E&#8722;03</td><td char="." align="char">4.04E&#8722;01</td><td char="." align="char">8.73E&#8722;01</td></tr><tr><td>PLA2G2E</td><td>1.99E&#8722;11</td><td>9.69E&#8722;06</td><td>6.35E&#8722;04</td><td char="." align="char">2.24E&#8722;01</td><td char="." align="char">1.04E&#8722;03</td></tr><tr><td>SCUBE2</td><td>4.93E&#8722;08</td><td>4.20E&#8722;06</td><td>1.94E&#8722;03</td><td char="." align="char">7.52E&#8722;04</td><td char="." align="char">2.49E&#8722;03</td></tr><tr><td>SH2B1</td><td>1.29E&#8722;11</td><td>2.68E&#8722;08</td><td>1.28E&#8722;06</td><td char="." align="char">5.99E&#8722;03</td><td char="." align="char">6.13E&#8722;03</td></tr><tr><td>SLC24A1</td><td>1.06E&#8722;09</td><td>5.12E&#8722;08</td><td>4.70E&#8722;03</td><td char="." align="char">2.26E&#8722;05</td><td char="." align="char">1.92E&#8722;04</td></tr><tr><td>SLC39A7</td><td>1.17E&#8722;07</td><td>4.49E&#8722;06</td><td>1.72E&#8722;04</td><td char="." align="char">3.57E&#8722;03</td><td char="." align="char">9.01E&#8722;05</td></tr><tr><td>SPBC25</td><td>1.28E&#8722;11</td><td>5.89E&#8722;06</td><td>2.90E&#8722;05</td><td char="." align="char">1.48E&#8722;03</td><td char="." align="char">2.39E&#8722;03</td></tr><tr><td>THBD</td><td>1.02E&#8722;14</td><td>1.78E&#8722;06</td><td>3.81E&#8722;03</td><td char="." align="char">1.79E&#8722;03</td><td char="." align="char">8.01E&#8722;04</td></tr><tr><td>TXNIP</td><td>8.99E&#8722;08</td><td>1.85E&#8722;07</td><td>9.15E&#8722;04</td><td char="." align="char">2.85E&#8722;01</td><td char="." align="char">1.25E&#8722;01</td></tr><tr><td>UBE2E3</td><td>1.55E&#8722;15</td><td>1.31E&#8722;07</td><td>5.94E&#8722;04</td><td char="." align="char">4.08E&#8722;04</td><td char="." align="char">3.28E&#8722;02</td></tr><tr><td>ZNF230</td><td>1.60E&#8722;09</td><td>3.87E&#8722;09</td><td>1.90E&#8722;09</td><td char="." align="char">6.37E&#8722;04</td><td char="." align="char">1.03E&#8722;03</td></tr><tr><td>WIPF1</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td><td char="." align="char">6.92E&#8722;06</td><td char="." align="char">7.80E&#8722;02</td></tr></tbody>
###xml 796 2728 796 2728 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="3">Gene</th><th>WIPF1 correlation</th><th>WIPF1 correlation</th><th>WIPF1 correlation</th><th>Cox regression Wald test</th><th>Cox regression Wald test</th></tr><tr><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th></tr><tr><th>Aronow data</th><th>Ayers data</th><th>Staub data</th><th>Wang data</th><th>Phillips data</th></tr></thead><tbody><tr><td>AGGF1</td><td>1.01E&#8722;09</td><td>6.40E&#8722;06</td><td>6.66E&#8722;03</td><td char="." align="char">4.74E&#8722;01</td><td char="." align="char">7.74E&#8722;01</td></tr><tr><td>AVEN</td><td>1.87E&#8722;10</td><td>1.04E&#8722;08</td><td>9.21E&#8722;08</td><td char="." align="char">1.23E&#8722;04</td><td char="." align="char">6.37E&#8722;04</td></tr><tr><td>AXL</td><td>3.15E-07</td><td>4.18E-06</td><td>1.27E-04</td><td char="." align="char">9.10E-02</td><td char="." align="char">2.23E-05</td></tr><tr><td>BIN1</td><td>9.45E-08</td><td>4.09E-08</td><td>1.57E-04</td><td char="." align="char">8.26E-02</td><td char="." align="char">1.01E-02</td></tr><tr><td>C12orf29</td><td>9.28E-07</td><td>4.99E-07</td><td>9.31E-04</td><td char="." align="char">4.75E-02</td><td char="." align="char">7.31E-06</td></tr><tr><td>C12orf43</td><td>9.05E-12</td><td>1.61E-09</td><td>3.27E-03</td><td char="." align="char">2.46E-02</td><td char="." align="char">1.35E-04</td></tr><tr><td>C1QB</td><td>4.44E-16</td><td>6.73E-07</td><td>9.96E&#8722;04</td><td char="." align="char">1.76E&#8722;02</td><td char="." align="char">1.56E&#8722;02</td></tr><tr><td>CCL16</td><td>8.44E&#8722;15</td><td>9.04E&#8722;10</td><td>3.02E-04</td><td char="." align="char">4.16E&#8722;03</td><td char="." align="char">9.65E&#8722;04</td></tr><tr><td>CHRDL1</td><td>1.22E&#8722;09</td><td>1.17E&#8722;07</td><td>2.10E&#8722;03</td><td char="." align="char">1.34E&#8722;03</td><td char="." align="char">5.83E&#8722;03</td></tr><tr><td>CYLC1</td><td>9.27E&#8722;12</td><td>1.91E&#8722;06</td><td>5.33E&#8722;04</td><td char="." align="char">1.16E&#8722;03</td><td char="." align="char">2.38E&#8722;01</td></tr><tr><td>DDX50</td><td>3.69E&#8722;07</td><td>3.60E&#8722;09</td><td>1.35E&#8722;08</td><td char="." align="char">5.63E&#8722;04</td><td char="." align="char">7.08E&#8722;03</td></tr><tr><td>DECR2</td><td>4.89E&#8722;12</td><td>4.55E&#8722;07</td><td>8.30E&#8722;07</td><td char="." align="char">8.97E&#8722;04</td><td char="." align="char">1.46E&#8722;04</td></tr><tr><td>DEDD</td><td>7.73E&#8722;12</td><td>4.91E&#8722;08</td><td>6.10E&#8722;11</td><td char="." align="char">1.48E&#8722;03</td><td char="." align="char">2.74E&#8722;02</td></tr><tr><td>DTX4</td><td>4.00E&#8722;09</td><td>3.28E&#8722;07</td><td>7.26E&#8722;04</td><td char="." align="char">7.73E&#8722;01</td><td char="." align="char">5.25E&#8722;05</td></tr><tr><td>EFHD2</td><td>3.97E&#8722;08</td><td>2.55E&#8722;06</td><td>3.42E&#8722;03</td><td char="." align="char">2.05E&#8722;01</td><td char="." align="char">2.42E&#8722;02</td></tr><tr><td>GTPBP2</td><td>4.64E&#8722;12</td><td>3.01E&#8722;10</td><td>1.26E&#8722;05</td><td char="." align="char">1.55E&#8722;05</td><td char="." align="char">1.63E&#8722;02</td></tr><tr><td>HSPA14</td><td>1.18E&#8722;12</td><td>2.92E-06</td><td>1.84E-03</td><td char="." align="char">6.09E-01</td><td char="." align="char">6.07E-03</td></tr><tr><td>IPW</td><td>9.49E-10</td><td>2.44E-07</td><td>1.64E-05</td><td char="." align="char">2.38E-03</td><td char="." align="char">3.69E-02</td></tr><tr><td>MADCAM1</td><td>1.39E-08</td><td>2.19E-06</td><td>1.16E-03</td><td char="." align="char">3.89E-01</td><td char="." align="char">1.22E-02</td></tr><tr><td>MINA</td><td>0.00E+00</td><td>6.98E-06</td><td>8.23E-05</td><td char="." align="char">9.65E-02</td><td char="." align="char">5.60E-03</td></tr><tr><td>MOBKL2B</td><td>8.13E-12</td><td>4.70E-06</td><td>5.86E-03</td><td char="." align="char">1.61E&#8722;01</td><td char="." align="char">9.03E&#8722;01</td></tr><tr><td>MRPL16</td><td>1.48E&#8722;09</td><td>9.52E&#8722;10</td><td>8.58E&#8722;04</td><td char="." align="char">1.36E&#8722;01</td><td char="." align="char">4.49E&#8722;02</td></tr><tr><td>MS4A12</td><td>1.36E&#8722;13</td><td>2.77E&#8722;10</td><td>2.02E&#8722;04</td><td char="." align="char">4.64E&#8722;01</td><td char="." align="char">1.02E&#8722;03</td></tr><tr><td>NF1</td><td>1.31E&#8722;14</td><td>2.16E&#8722;07</td><td>6.94E&#8722;03</td><td char="." align="char">3.51E&#8722;01</td><td char="." align="char">6.15E&#8722;02</td></tr><tr><td>NIP7</td><td>1.92E&#8722;09</td><td>2.03E&#8722;08</td><td>7.09E&#8722;03</td><td char="." align="char">4.60E&#8722;01</td><td char="." align="char">8.45E&#8722;01</td></tr><tr><td>NLK</td><td>0.00E+00</td><td>3.29E&#8722;09</td><td>6.99E&#8722;05</td><td char="." align="char">7.86E&#8722;03</td><td char="." align="char">3.52E&#8722;02</td></tr><tr><td>NT5E</td><td>3.61E&#8722;12</td><td>4.34E&#8722;09</td><td>1.05E&#8722;04</td><td char="." align="char">5.92E&#8722;06</td><td char="." align="char">4.19E&#8722;03</td></tr><tr><td>PGM1</td><td>3.93E&#8722;07</td><td>3.17E&#8722;07</td><td>4.95E&#8722;03</td><td char="." align="char">4.04E&#8722;01</td><td char="." align="char">8.73E&#8722;01</td></tr><tr><td>PLA2G2E</td><td>1.99E&#8722;11</td><td>9.69E&#8722;06</td><td>6.35E&#8722;04</td><td char="." align="char">2.24E&#8722;01</td><td char="." align="char">1.04E&#8722;03</td></tr><tr><td>SCUBE2</td><td>4.93E&#8722;08</td><td>4.20E&#8722;06</td><td>1.94E&#8722;03</td><td char="." align="char">7.52E&#8722;04</td><td char="." align="char">2.49E&#8722;03</td></tr><tr><td>SH2B1</td><td>1.29E&#8722;11</td><td>2.68E&#8722;08</td><td>1.28E&#8722;06</td><td char="." align="char">5.99E&#8722;03</td><td char="." align="char">6.13E&#8722;03</td></tr><tr><td>SLC24A1</td><td>1.06E&#8722;09</td><td>5.12E&#8722;08</td><td>4.70E&#8722;03</td><td char="." align="char">2.26E&#8722;05</td><td char="." align="char">1.92E&#8722;04</td></tr><tr><td>SLC39A7</td><td>1.17E&#8722;07</td><td>4.49E&#8722;06</td><td>1.72E&#8722;04</td><td char="." align="char">3.57E&#8722;03</td><td char="." align="char">9.01E&#8722;05</td></tr><tr><td>SPBC25</td><td>1.28E&#8722;11</td><td>5.89E&#8722;06</td><td>2.90E&#8722;05</td><td char="." align="char">1.48E&#8722;03</td><td char="." align="char">2.39E&#8722;03</td></tr><tr><td>THBD</td><td>1.02E&#8722;14</td><td>1.78E&#8722;06</td><td>3.81E&#8722;03</td><td char="." align="char">1.79E&#8722;03</td><td char="." align="char">8.01E&#8722;04</td></tr><tr><td>TXNIP</td><td>8.99E&#8722;08</td><td>1.85E&#8722;07</td><td>9.15E&#8722;04</td><td char="." align="char">2.85E&#8722;01</td><td char="." align="char">1.25E&#8722;01</td></tr><tr><td>UBE2E3</td><td>1.55E&#8722;15</td><td>1.31E&#8722;07</td><td>5.94E&#8722;04</td><td char="." align="char">4.08E&#8722;04</td><td char="." align="char">3.28E&#8722;02</td></tr><tr><td>ZNF230</td><td>1.60E&#8722;09</td><td>3.87E&#8722;09</td><td>1.90E&#8722;09</td><td char="." align="char">6.37E&#8722;04</td><td char="." align="char">1.03E&#8722;03</td></tr><tr><td>WIPF1</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td><td char="." align="char">6.92E&#8722;06</td><td char="." align="char">7.80E&#8722;02</td></tr></tbody></table>
###xml 2953 2954 2953 2954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 3144 3145 3144 3145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM2">2</xref>
###xml 2728 3146 2728 3146 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36">A core set of 38 genes of the WIPF1 module (discovered in the Aronow data set) for which WIPF1 coexpression could be double validated in the Ayers and Staub data sets at stringent thresholds are listed here together with the <italic>p</italic> values of their WIPF1 correlation tests and of their survival/relapse association tests. A list of results for the full set of 112 genes of the WIPF1 module is given in Supplementary Table&#160;<xref ref-type="supplementary-material" rid="MOESM2">2</xref>.</p>
###xml 2728 3146 2728 3146 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36">A core set of 38 genes of the WIPF1 module (discovered in the Aronow data set) for which WIPF1 coexpression could be double validated in the Ayers and Staub data sets at stringent thresholds are listed here together with the <italic>p</italic> values of their WIPF1 correlation tests and of their survival/relapse association tests. A list of results for the full set of 112 genes of the WIPF1 module is given in Supplementary Table&#160;<xref ref-type="supplementary-material" rid="MOESM2">2</xref>.</p></table-wrap-foot>
###xml 673 3146 673 3146 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="35">Summary of WIPF1 correlation and survival/relapse association for 38 core genes of the WIPF1 module and WIPF1 itself</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Gene</th><th>WIPF1 correlation</th><th>WIPF1 correlation</th><th>WIPF1 correlation</th><th>Cox regression Wald test</th><th>Cox regression Wald test</th></tr><tr><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th><th><italic>p</italic> Value</th></tr><tr><th>Aronow data</th><th>Ayers data</th><th>Staub data</th><th>Wang data</th><th>Phillips data</th></tr></thead><tbody><tr><td>AGGF1</td><td>1.01E&#8722;09</td><td>6.40E&#8722;06</td><td>6.66E&#8722;03</td><td char="." align="char">4.74E&#8722;01</td><td char="." align="char">7.74E&#8722;01</td></tr><tr><td>AVEN</td><td>1.87E&#8722;10</td><td>1.04E&#8722;08</td><td>9.21E&#8722;08</td><td char="." align="char">1.23E&#8722;04</td><td char="." align="char">6.37E&#8722;04</td></tr><tr><td>AXL</td><td>3.15E-07</td><td>4.18E-06</td><td>1.27E-04</td><td char="." align="char">9.10E-02</td><td char="." align="char">2.23E-05</td></tr><tr><td>BIN1</td><td>9.45E-08</td><td>4.09E-08</td><td>1.57E-04</td><td char="." align="char">8.26E-02</td><td char="." align="char">1.01E-02</td></tr><tr><td>C12orf29</td><td>9.28E-07</td><td>4.99E-07</td><td>9.31E-04</td><td char="." align="char">4.75E-02</td><td char="." align="char">7.31E-06</td></tr><tr><td>C12orf43</td><td>9.05E-12</td><td>1.61E-09</td><td>3.27E-03</td><td char="." align="char">2.46E-02</td><td char="." align="char">1.35E-04</td></tr><tr><td>C1QB</td><td>4.44E-16</td><td>6.73E-07</td><td>9.96E&#8722;04</td><td char="." align="char">1.76E&#8722;02</td><td char="." align="char">1.56E&#8722;02</td></tr><tr><td>CCL16</td><td>8.44E&#8722;15</td><td>9.04E&#8722;10</td><td>3.02E-04</td><td char="." align="char">4.16E&#8722;03</td><td char="." align="char">9.65E&#8722;04</td></tr><tr><td>CHRDL1</td><td>1.22E&#8722;09</td><td>1.17E&#8722;07</td><td>2.10E&#8722;03</td><td char="." align="char">1.34E&#8722;03</td><td char="." align="char">5.83E&#8722;03</td></tr><tr><td>CYLC1</td><td>9.27E&#8722;12</td><td>1.91E&#8722;06</td><td>5.33E&#8722;04</td><td char="." align="char">1.16E&#8722;03</td><td char="." align="char">2.38E&#8722;01</td></tr><tr><td>DDX50</td><td>3.69E&#8722;07</td><td>3.60E&#8722;09</td><td>1.35E&#8722;08</td><td char="." align="char">5.63E&#8722;04</td><td char="." align="char">7.08E&#8722;03</td></tr><tr><td>DECR2</td><td>4.89E&#8722;12</td><td>4.55E&#8722;07</td><td>8.30E&#8722;07</td><td char="." align="char">8.97E&#8722;04</td><td char="." align="char">1.46E&#8722;04</td></tr><tr><td>DEDD</td><td>7.73E&#8722;12</td><td>4.91E&#8722;08</td><td>6.10E&#8722;11</td><td char="." align="char">1.48E&#8722;03</td><td char="." align="char">2.74E&#8722;02</td></tr><tr><td>DTX4</td><td>4.00E&#8722;09</td><td>3.28E&#8722;07</td><td>7.26E&#8722;04</td><td char="." align="char">7.73E&#8722;01</td><td char="." align="char">5.25E&#8722;05</td></tr><tr><td>EFHD2</td><td>3.97E&#8722;08</td><td>2.55E&#8722;06</td><td>3.42E&#8722;03</td><td char="." align="char">2.05E&#8722;01</td><td char="." align="char">2.42E&#8722;02</td></tr><tr><td>GTPBP2</td><td>4.64E&#8722;12</td><td>3.01E&#8722;10</td><td>1.26E&#8722;05</td><td char="." align="char">1.55E&#8722;05</td><td char="." align="char">1.63E&#8722;02</td></tr><tr><td>HSPA14</td><td>1.18E&#8722;12</td><td>2.92E-06</td><td>1.84E-03</td><td char="." align="char">6.09E-01</td><td char="." align="char">6.07E-03</td></tr><tr><td>IPW</td><td>9.49E-10</td><td>2.44E-07</td><td>1.64E-05</td><td char="." align="char">2.38E-03</td><td char="." align="char">3.69E-02</td></tr><tr><td>MADCAM1</td><td>1.39E-08</td><td>2.19E-06</td><td>1.16E-03</td><td char="." align="char">3.89E-01</td><td char="." align="char">1.22E-02</td></tr><tr><td>MINA</td><td>0.00E+00</td><td>6.98E-06</td><td>8.23E-05</td><td char="." align="char">9.65E-02</td><td char="." align="char">5.60E-03</td></tr><tr><td>MOBKL2B</td><td>8.13E-12</td><td>4.70E-06</td><td>5.86E-03</td><td char="." align="char">1.61E&#8722;01</td><td char="." align="char">9.03E&#8722;01</td></tr><tr><td>MRPL16</td><td>1.48E&#8722;09</td><td>9.52E&#8722;10</td><td>8.58E&#8722;04</td><td char="." align="char">1.36E&#8722;01</td><td char="." align="char">4.49E&#8722;02</td></tr><tr><td>MS4A12</td><td>1.36E&#8722;13</td><td>2.77E&#8722;10</td><td>2.02E&#8722;04</td><td char="." align="char">4.64E&#8722;01</td><td char="." align="char">1.02E&#8722;03</td></tr><tr><td>NF1</td><td>1.31E&#8722;14</td><td>2.16E&#8722;07</td><td>6.94E&#8722;03</td><td char="." align="char">3.51E&#8722;01</td><td char="." align="char">6.15E&#8722;02</td></tr><tr><td>NIP7</td><td>1.92E&#8722;09</td><td>2.03E&#8722;08</td><td>7.09E&#8722;03</td><td char="." align="char">4.60E&#8722;01</td><td char="." align="char">8.45E&#8722;01</td></tr><tr><td>NLK</td><td>0.00E+00</td><td>3.29E&#8722;09</td><td>6.99E&#8722;05</td><td char="." align="char">7.86E&#8722;03</td><td char="." align="char">3.52E&#8722;02</td></tr><tr><td>NT5E</td><td>3.61E&#8722;12</td><td>4.34E&#8722;09</td><td>1.05E&#8722;04</td><td char="." align="char">5.92E&#8722;06</td><td char="." align="char">4.19E&#8722;03</td></tr><tr><td>PGM1</td><td>3.93E&#8722;07</td><td>3.17E&#8722;07</td><td>4.95E&#8722;03</td><td char="." align="char">4.04E&#8722;01</td><td char="." align="char">8.73E&#8722;01</td></tr><tr><td>PLA2G2E</td><td>1.99E&#8722;11</td><td>9.69E&#8722;06</td><td>6.35E&#8722;04</td><td char="." align="char">2.24E&#8722;01</td><td char="." align="char">1.04E&#8722;03</td></tr><tr><td>SCUBE2</td><td>4.93E&#8722;08</td><td>4.20E&#8722;06</td><td>1.94E&#8722;03</td><td char="." align="char">7.52E&#8722;04</td><td char="." align="char">2.49E&#8722;03</td></tr><tr><td>SH2B1</td><td>1.29E&#8722;11</td><td>2.68E&#8722;08</td><td>1.28E&#8722;06</td><td char="." align="char">5.99E&#8722;03</td><td char="." align="char">6.13E&#8722;03</td></tr><tr><td>SLC24A1</td><td>1.06E&#8722;09</td><td>5.12E&#8722;08</td><td>4.70E&#8722;03</td><td char="." align="char">2.26E&#8722;05</td><td char="." align="char">1.92E&#8722;04</td></tr><tr><td>SLC39A7</td><td>1.17E&#8722;07</td><td>4.49E&#8722;06</td><td>1.72E&#8722;04</td><td char="." align="char">3.57E&#8722;03</td><td char="." align="char">9.01E&#8722;05</td></tr><tr><td>SPBC25</td><td>1.28E&#8722;11</td><td>5.89E&#8722;06</td><td>2.90E&#8722;05</td><td char="." align="char">1.48E&#8722;03</td><td char="." align="char">2.39E&#8722;03</td></tr><tr><td>THBD</td><td>1.02E&#8722;14</td><td>1.78E&#8722;06</td><td>3.81E&#8722;03</td><td char="." align="char">1.79E&#8722;03</td><td char="." align="char">8.01E&#8722;04</td></tr><tr><td>TXNIP</td><td>8.99E&#8722;08</td><td>1.85E&#8722;07</td><td>9.15E&#8722;04</td><td char="." align="char">2.85E&#8722;01</td><td char="." align="char">1.25E&#8722;01</td></tr><tr><td>UBE2E3</td><td>1.55E&#8722;15</td><td>1.31E&#8722;07</td><td>5.94E&#8722;04</td><td char="." align="char">4.08E&#8722;04</td><td char="." align="char">3.28E&#8722;02</td></tr><tr><td>ZNF230</td><td>1.60E&#8722;09</td><td>3.87E&#8722;09</td><td>1.90E&#8722;09</td><td char="." align="char">6.37E&#8722;04</td><td char="." align="char">1.03E&#8722;03</td></tr><tr><td>WIPF1</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td><td char="." align="char">6.92E&#8722;06</td><td char="." align="char">7.80E&#8722;02</td></tr></tbody></table><table-wrap-foot><p textid="36">A core set of 38 genes of the WIPF1 module (discovered in the Aronow data set) for which WIPF1 coexpression could be double validated in the Ayers and Staub data sets at stringent thresholds are listed here together with the <italic>p</italic> values of their WIPF1 correlation tests and of their survival/relapse association tests. A list of results for the full set of 112 genes of the WIPF1 module is given in Supplementary Table&#160;<xref ref-type="supplementary-material" rid="MOESM2">2</xref>.</p></table-wrap-foot></table-wrap>
###xml 494 502 <span type="species:ncbi:9606">patients</span>
We fitted Cox regression models for genes of the WIPF1 signature and tested their individual association with survival using Wald tests on microarray expression studies of 286 breast cancers (Wang et al., GSE2034) and 77 high grade-gliomas (Phillips et al., GSE4271). We found that a high fraction (50 of 112) of genes of the WIPF1 signature were significantly associated with survival (p < 0.05) in both studies. A list of 38 genes for which significant correlation of WIPF1 expression across patients was validated in Aronow, Ayers, and Staub data sets is given in Table 1 together with results of statistical tests on WIPF1 correlation and survival/relapse association. Table 1Summary of WIPF1 correlation and survival/relapse association for 38 core genes of the WIPF1 module and WIPF1 itselfGeneWIPF1 correlationWIPF1 correlationWIPF1 correlationCox regression Wald testCox regression Wald testp Valuep Valuep Valuep Valuep ValueAronow dataAyers dataStaub dataWang dataPhillips dataAGGF11.01E-096.40E-066.66E-034.74E-017.74E-01AVEN1.87E-101.04E-089.21E-081.23E-046.37E-04AXL3.15E-074.18E-061.27E-049.10E-022.23E-05BIN19.45E-084.09E-081.57E-048.26E-021.01E-02C12orf299.28E-074.99E-079.31E-044.75E-027.31E-06C12orf439.05E-121.61E-093.27E-032.46E-021.35E-04C1QB4.44E-166.73E-079.96E-041.76E-021.56E-02CCL168.44E-159.04E-103.02E-044.16E-039.65E-04CHRDL11.22E-091.17E-072.10E-031.34E-035.83E-03CYLC19.27E-121.91E-065.33E-041.16E-032.38E-01DDX503.69E-073.60E-091.35E-085.63E-047.08E-03DECR24.89E-124.55E-078.30E-078.97E-041.46E-04DEDD7.73E-124.91E-086.10E-111.48E-032.74E-02DTX44.00E-093.28E-077.26E-047.73E-015.25E-05EFHD23.97E-082.55E-063.42E-032.05E-012.42E-02GTPBP24.64E-123.01E-101.26E-051.55E-051.63E-02HSPA141.18E-122.92E-061.84E-036.09E-016.07E-03IPW9.49E-102.44E-071.64E-052.38E-033.69E-02MADCAM11.39E-082.19E-061.16E-033.89E-011.22E-02MINA0.00E+006.98E-068.23E-059.65E-025.60E-03MOBKL2B8.13E-124.70E-065.86E-031.61E-019.03E-01MRPL161.48E-099.52E-108.58E-041.36E-014.49E-02MS4A121.36E-132.77E-102.02E-044.64E-011.02E-03NF11.31E-142.16E-076.94E-033.51E-016.15E-02NIP71.92E-092.03E-087.09E-034.60E-018.45E-01NLK0.00E+003.29E-096.99E-057.86E-033.52E-02NT5E3.61E-124.34E-091.05E-045.92E-064.19E-03PGM13.93E-073.17E-074.95E-034.04E-018.73E-01PLA2G2E1.99E-119.69E-066.35E-042.24E-011.04E-03SCUBE24.93E-084.20E-061.94E-037.52E-042.49E-03SH2B11.29E-112.68E-081.28E-065.99E-036.13E-03SLC24A11.06E-095.12E-084.70E-032.26E-051.92E-04SLC39A71.17E-074.49E-061.72E-043.57E-039.01E-05SPBC251.28E-115.89E-062.90E-051.48E-032.39E-03THBD1.02E-141.78E-063.81E-031.79E-038.01E-04TXNIP8.99E-081.85E-079.15E-042.85E-011.25E-01UBE2E31.55E-151.31E-075.94E-044.08E-043.28E-02ZNF2301.60E-093.87E-091.90E-096.37E-041.03E-03WIPF1---6.92E-067.80E-02A core set of 38 genes of the WIPF1 module (discovered in the Aronow data set) for which WIPF1 coexpression could be double validated in the Ayers and Staub data sets at stringent thresholds are listed here together with the p values of their WIPF1 correlation tests and of their survival/relapse association tests. A list of results for the full set of 112 genes of the WIPF1 module is given in Supplementary Table 2.
###end p 34
###begin p 35
Summary of WIPF1 correlation and survival/relapse association for 38 core genes of the WIPF1 module and WIPF1 itself
###end p 35
###begin p 36
###xml 225 226 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 416 417 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM2">2</xref>
A core set of 38 genes of the WIPF1 module (discovered in the Aronow data set) for which WIPF1 coexpression could be double validated in the Ayers and Staub data sets at stringent thresholds are listed here together with the p values of their WIPF1 correlation tests and of their survival/relapse association tests. A list of results for the full set of 112 genes of the WIPF1 module is given in Supplementary Table 2.
###end p 36
###begin p 37
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 479 480 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 699 700 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 719 720 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 774 775 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 965 971 965 971 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 1067 1068 1067 1068 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1101 1102 1101 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1256 1257 1256 1257 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1345 1356 1345 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper curve</italic>
###xml 1385 1386 1385 1386 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1584 1585 1584 1585 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1789 1790 1789 1790 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1796 1797 1796 1797 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1873 1874 1873 1874 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1881 1882 1881 1882 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 971 2081 971 2081 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38">The WIPF1 module identifies breast cancer and glioma patients with better prognosis. Histogram (<bold>a</bold>) visualizes the distribution of <italic>p</italic> values resulting from logrank tests for the association of profiles of single genes of the WIPF1 module with relapse in the Wang data on breast cancers. <bold>b</bold> The Kaplan&#8211;Meier curves for breast cancer patients assigned to the groups cluster &#8220;A&#8221; (<italic>upper curve</italic>) or cluster &#8220;B&#8221;. Histogram (<bold>c</bold>) visualizes the distribution of p values resulting from logrank tests for the association of single expression profiles of the WIPF1 coexpressed genes with relapse in the Phillips data on gliomas. <bold>d</bold> The Kaplan&#8211;Meier curves for glioma patients assigned to the groups &#8220;A&#8221; (upper curve) or &#8220;B&#8221;. Note the strong deviation from the uniform distribution (that would result from chance association) in plots (<bold>a</bold>) or (<bold>c</bold>) and the consistently higher fractions of survivors among &#8220;A&#8221; patients in (<bold>b</bold>) and (<bold>d</bold>). These plots visualize the high fraction of genes of the WIPF1 module that are individually associated with survival in breast and brain cancers and the survival significance of the complete module</p>
###xml 971 2081 971 2081 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38">The WIPF1 module identifies breast cancer and glioma patients with better prognosis. Histogram (<bold>a</bold>) visualizes the distribution of <italic>p</italic> values resulting from logrank tests for the association of profiles of single genes of the WIPF1 module with relapse in the Wang data on breast cancers. <bold>b</bold> The Kaplan&#8211;Meier curves for breast cancer patients assigned to the groups cluster &#8220;A&#8221; (<italic>upper curve</italic>) or cluster &#8220;B&#8221;. Histogram (<bold>c</bold>) visualizes the distribution of p values resulting from logrank tests for the association of single expression profiles of the WIPF1 coexpressed genes with relapse in the Phillips data on gliomas. <bold>d</bold> The Kaplan&#8211;Meier curves for glioma patients assigned to the groups &#8220;A&#8221; (upper curve) or &#8220;B&#8221;. Note the strong deviation from the uniform distribution (that would result from chance association) in plots (<bold>a</bold>) or (<bold>c</bold>) and the consistently higher fractions of survivors among &#8220;A&#8221; patients in (<bold>b</bold>) and (<bold>d</bold>). These plots visualize the high fraction of genes of the WIPF1 module that are individually associated with survival in breast and brain cancers and the survival significance of the complete module</p></caption>
###xml 2081 2081 2081 2081 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="109_2009_467_Fig4_HTML" id="MO4"/>
###xml 965 2081 965 2081 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="38">The WIPF1 module identifies breast cancer and glioma patients with better prognosis. Histogram (<bold>a</bold>) visualizes the distribution of <italic>p</italic> values resulting from logrank tests for the association of profiles of single genes of the WIPF1 module with relapse in the Wang data on breast cancers. <bold>b</bold> The Kaplan&#8211;Meier curves for breast cancer patients assigned to the groups cluster &#8220;A&#8221; (<italic>upper curve</italic>) or cluster &#8220;B&#8221;. Histogram (<bold>c</bold>) visualizes the distribution of p values resulting from logrank tests for the association of single expression profiles of the WIPF1 coexpressed genes with relapse in the Phillips data on gliomas. <bold>d</bold> The Kaplan&#8211;Meier curves for glioma patients assigned to the groups &#8220;A&#8221; (upper curve) or &#8220;B&#8221;. Note the strong deviation from the uniform distribution (that would result from chance association) in plots (<bold>a</bold>) or (<bold>c</bold>) and the consistently higher fractions of survivors among &#8220;A&#8221; patients in (<bold>b</bold>) and (<bold>d</bold>). These plots visualize the high fraction of genes of the WIPF1 module that are individually associated with survival in breast and brain cancers and the survival significance of the complete module</p></caption><graphic position="anchor" xlink:href="109_2009_467_Fig4_HTML" id="MO4"/></fig>
###xml 164 171 <span type="species:ncbi:9606">patient</span>
###xml 235 243 <span type="species:ncbi:9606">patients</span>
###xml 332 340 <span type="species:ncbi:9606">patients</span>
###xml 437 445 <span type="species:ncbi:9606">patients</span>
###xml 525 532 <span type="species:ncbi:9606">patient</span>
###xml 580 588 <span type="species:ncbi:9606">patients</span>
###xml 666 674 <span type="species:ncbi:9606">patients</span>
###xml 930 938 <span type="species:ncbi:9606">patients</span>
###xml 1024 1032 <span type="species:ncbi:9606">patients</span>
###xml 1300 1308 <span type="species:ncbi:9606">patients</span>
###xml 1621 1629 <span type="species:ncbi:9606">patients</span>
###xml 1860 1868 <span type="species:ncbi:9606">patients</span>
We next applied the k-nearest neighbor classifier trained on Aronow/Ayers data directly on the data sets of breast cancers and high-grade gliomas to stratify these patient collectives. Among the microarray profiles of 286 breast tumor patients of a data set of Wang et al. (GSE2034), we identified 59 of the cluster "A" type. These patients had a remarkably better prognosis regarding time to relapse, the difference between cluster "A" patients, and others being significant at p = 0.0045 (see Fig. 4a and b). In the glioma patient set of Phillips et al. (GSE4271), 24 out of 77 patients were assigned the cluster "A" type by classification. The cluster "A" glioma patients had a better prognosis (p = 0.012, see Fig. 4c and d). In conclusion, the application of the WIPF1 k-nearest neighbor classifier on two different tumor sets further validates the predictive value of the WIPF1 coexpression module for the identification of patients with favorable prognosis. Fig. 4The WIPF1 module identifies breast cancer and glioma patients with better prognosis. Histogram (a) visualizes the distribution of p values resulting from logrank tests for the association of profiles of single genes of the WIPF1 module with relapse in the Wang data on breast cancers. b The Kaplan-Meier curves for breast cancer patients assigned to the groups cluster "A" (upper curve) or cluster "B". Histogram (c) visualizes the distribution of p values resulting from logrank tests for the association of single expression profiles of the WIPF1 coexpressed genes with relapse in the Phillips data on gliomas. d The Kaplan-Meier curves for glioma patients assigned to the groups "A" (upper curve) or "B". Note the strong deviation from the uniform distribution (that would result from chance association) in plots (a) or (c) and the consistently higher fractions of survivors among "A" patients in (b) and (d). These plots visualize the high fraction of genes of the WIPF1 module that are individually associated with survival in breast and brain cancers and the survival significance of the complete module
###end p 37
###begin p 38
###xml 96 97 96 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 285 286 285 286 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 374 385 374 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper curve</italic>
###xml 414 415 414 415 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 613 614 613 614 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 818 819 818 819 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 825 826 825 826 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 902 903 902 903 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 910 911 910 911 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 329 337 <span type="species:ncbi:9606">patients</span>
###xml 650 658 <span type="species:ncbi:9606">patients</span>
###xml 889 897 <span type="species:ncbi:9606">patients</span>
The WIPF1 module identifies breast cancer and glioma patients with better prognosis. Histogram (a) visualizes the distribution of p values resulting from logrank tests for the association of profiles of single genes of the WIPF1 module with relapse in the Wang data on breast cancers. b The Kaplan-Meier curves for breast cancer patients assigned to the groups cluster "A" (upper curve) or cluster "B". Histogram (c) visualizes the distribution of p values resulting from logrank tests for the association of single expression profiles of the WIPF1 coexpressed genes with relapse in the Phillips data on gliomas. d The Kaplan-Meier curves for glioma patients assigned to the groups "A" (upper curve) or "B". Note the strong deviation from the uniform distribution (that would result from chance association) in plots (a) or (c) and the consistently higher fractions of survivors among "A" patients in (b) and (d). These plots visualize the high fraction of genes of the WIPF1 module that are individually associated with survival in breast and brain cancers and the survival significance of the complete module
###end p 38
###begin title 39
The WIPF1 signature has links to c-myc, p53, proliferation, and apoptosis
###end title 39
###begin p 40
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 268 281 268 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">proliferation</italic>
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 1085 1086 1085 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1178 1184 1178 1184 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 1820 1821 1820 1821 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1864 1865 1864 1865 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1907 1908 1907 1908 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1184 1952 1184 1952 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="41">Similarity of the WIPF1 and proliferation signatures. We determined average profiles (signature centroids) of the WIPF1 and the proliferation signatures in three data sets. Only 107 of 112 WIPF1 module genes with concordant lower expression in cluster X of the WIPF1 signature were considered for this analysis. Signature centroids were determined using averaging over all genes for each patient. The scatter plots visualize the strength of the correlation between proliferation signature and WIPF1 signature. Coordinates of each data point correspond to a single patient&#8217;s averaged mean-centered expression values for both signatures, <bold>a</bold> for the Staub colorectal cancer data set, <bold>b</bold> for the Wang breast cancer data set, and <bold>c</bold> for the Phillips glioma expression data set</p>
###xml 1184 1952 1184 1952 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="41">Similarity of the WIPF1 and proliferation signatures. We determined average profiles (signature centroids) of the WIPF1 and the proliferation signatures in three data sets. Only 107 of 112 WIPF1 module genes with concordant lower expression in cluster X of the WIPF1 signature were considered for this analysis. Signature centroids were determined using averaging over all genes for each patient. The scatter plots visualize the strength of the correlation between proliferation signature and WIPF1 signature. Coordinates of each data point correspond to a single patient&#8217;s averaged mean-centered expression values for both signatures, <bold>a</bold> for the Staub colorectal cancer data set, <bold>b</bold> for the Wang breast cancer data set, and <bold>c</bold> for the Phillips glioma expression data set</p></caption>
###xml 1952 1952 1952 1952 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="109_2009_467_Fig5_HTML" id="MO5"/>
###xml 1178 1952 1178 1952 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="41">Similarity of the WIPF1 and proliferation signatures. We determined average profiles (signature centroids) of the WIPF1 and the proliferation signatures in three data sets. Only 107 of 112 WIPF1 module genes with concordant lower expression in cluster X of the WIPF1 signature were considered for this analysis. Signature centroids were determined using averaging over all genes for each patient. The scatter plots visualize the strength of the correlation between proliferation signature and WIPF1 signature. Coordinates of each data point correspond to a single patient&#8217;s averaged mean-centered expression values for both signatures, <bold>a</bold> for the Staub colorectal cancer data set, <bold>b</bold> for the Wang breast cancer data set, and <bold>c</bold> for the Phillips glioma expression data set</p></caption><graphic position="anchor" xlink:href="109_2009_467_Fig5_HTML" id="MO5"/></fig>
###xml 201 208 <span type="species:ncbi:9606">patient</span>
###xml 1572 1579 <span type="species:ncbi:9606">patient</span>
###xml 1748 1755 <span type="species:ncbi:9606">patient</span>
Because of the multitude of genes that are correlated with WIPF1 (see Fig. 1), we hypothesized that a dominating cancer-driving mechanism is linked to WIPF1 expression. It was frequently reported that patient prognosis is associated with the expression of a so-called proliferation signature. This term circumscribes a large set of signatures that can be pulled from a large set of genes deregulated during the cell cycle. To our knowledge, a link between the proliferation signature and colorectal cancer has not been established so far. We found that the WIPF1 signature does not have a substantial overlap to proliferation signatures. To investigate an indirect link to the transcriptional program of proliferation, we tested the proliferation signature described by Rosenwald et al. for correlation with our WIPF1 signature [36]. Correlation tests of signature centroids revealed that both signatures are significantly correlated in three data sets, the colorectal cancer data generated during this study, the Wang data on breast cancer, and the Phillips data on gliomas (see Fig. 5). This suggests a regulatory link of the WIPF1 signature with typical proliferation genes. Fig. 5Similarity of the WIPF1 and proliferation signatures. We determined average profiles (signature centroids) of the WIPF1 and the proliferation signatures in three data sets. Only 107 of 112 WIPF1 module genes with concordant lower expression in cluster X of the WIPF1 signature were considered for this analysis. Signature centroids were determined using averaging over all genes for each patient. The scatter plots visualize the strength of the correlation between proliferation signature and WIPF1 signature. Coordinates of each data point correspond to a single patient's averaged mean-centered expression values for both signatures, a for the Staub colorectal cancer data set, b for the Wang breast cancer data set, and c for the Phillips glioma expression data set
###end p 40
###begin p 41
###xml 636 637 636 637 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 680 681 680 681 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 723 724 723 724 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 388 395 <span type="species:ncbi:9606">patient</span>
###xml 564 571 <span type="species:ncbi:9606">patient</span>
Similarity of the WIPF1 and proliferation signatures. We determined average profiles (signature centroids) of the WIPF1 and the proliferation signatures in three data sets. Only 107 of 112 WIPF1 module genes with concordant lower expression in cluster X of the WIPF1 signature were considered for this analysis. Signature centroids were determined using averaging over all genes for each patient. The scatter plots visualize the strength of the correlation between proliferation signature and WIPF1 signature. Coordinates of each data point correspond to a single patient's averaged mean-centered expression values for both signatures, a for the Staub colorectal cancer data set, b for the Wang breast cancer data set, and c for the Phillips glioma expression data set
###end p 41
###begin p 42
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 788 789 788 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 996 997 996 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 1007 1008 1007 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 1360 1367 1360 1367 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 1367 1461 1367 1461 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43">Summaries of top literature subnetworks enriched with genes from the WIPF1 coexpression module</p>
###xml 1367 1461 1367 1461 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="43">Summaries of top literature subnetworks enriched with genes from the WIPF1 coexpression module</p></caption>
###xml 1461 1463 1461 1463 <td xmlns:xlink="http://www.w3.org/1999/xlink">No</td>
###xml 1463 1488 1463 1488 <td xmlns:xlink="http://www.w3.org/1999/xlink">General Molecular Network</td>
###xml 1488 1500 1488 1500 <td xmlns:xlink="http://www.w3.org/1999/xlink">GO Processes</td>
###xml 1500 1511 1500 1511 <td xmlns:xlink="http://www.w3.org/1999/xlink">Total nodes</td>
###xml 1511 1521 1511 1521 <td xmlns:xlink="http://www.w3.org/1999/xlink">Root nodes</td>
###xml 1521 1522 1521 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1521 1528 1521 1528 <td xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic>-Value</td>
###xml 1461 1528 1461 1528 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>No</td><td>General Molecular Network</td><td>GO Processes</td><td>Total nodes</td><td>Root nodes</td><td><italic>p</italic>-Value</td></tr>
###xml 1528 1529 1528 1529 <td xmlns:xlink="http://www.w3.org/1999/xlink">1</td>
###xml 1529 1581 1529 1581 <td xmlns:xlink="http://www.w3.org/1999/xlink">ADAM19, SLC25A10, CDC14a, UBE2E3, TXNIP (VDUP1), ...</td>
###xml 1581 1756 1581 1756 <td xmlns:xlink="http://www.w3.org/1999/xlink">Sulfate transport (8.1%; 7.943e&#8722;06), cell division (18.9%; 1.334e&#8722;05), mitosis (16.2%; 1.414e&#8722;05), M phase of mitotic cell cycle (16.2%; 1.598e&#8722;05), M phase (18.9%; 1.854e&#8722;05)</td>
###xml 1756 1758 1756 1758 <td xmlns:xlink="http://www.w3.org/1999/xlink">50</td>
###xml 1758 1760 1758 1760 <td xmlns:xlink="http://www.w3.org/1999/xlink">13</td>
###xml 1760 1768 1760 1768 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.38E&#8722;26</td>
###xml 1528 1768 1528 1768 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>1</td><td>ADAM19, SLC25A10, CDC14a, UBE2E3, TXNIP (VDUP1), ...</td><td>Sulfate transport (8.1%; 7.943e&#8722;06), cell division (18.9%; 1.334e&#8722;05), mitosis (16.2%; 1.414e&#8722;05), M phase of mitotic cell cycle (16.2%; 1.598e&#8722;05), M phase (18.9%; 1.854e&#8722;05)</td><td>50</td><td>13</td><td>4.38E&#8722;26</td></tr>
###xml 1768 1769 1768 1769 <td xmlns:xlink="http://www.w3.org/1999/xlink">2</td>
###xml 1769 1808 1769 1808 <td xmlns:xlink="http://www.w3.org/1999/xlink">REA, NLK, Chordin-like 1, Copine-1, ...</td>
###xml 1808 2112 1808 2112 <td xmlns:xlink="http://www.w3.org/1999/xlink">BMP signaling pathway (11.6%; 8.328e&#8722;08), positive regulation of osteoblast differentiation (9.3%; 1.255e&#8722;06), regulation of osteoblast differentiation (9.3%; 7.241e&#8722;06), transmembrane receptor protein serine/threonine kinase signaling pathway (11.6%; 1.533e&#8722;05), developmental process (67.4%; 2.095e&#8722;05)</td>
###xml 2112 2114 2112 2114 <td xmlns:xlink="http://www.w3.org/1999/xlink">50</td>
###xml 2114 2116 2114 2116 <td xmlns:xlink="http://www.w3.org/1999/xlink">12</td>
###xml 2116 2124 2116 2124 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.49E&#8722;23</td>
###xml 1768 2124 1768 2124 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>2</td><td>REA, NLK, Chordin-like 1, Copine-1, ...</td><td>BMP signaling pathway (11.6%; 8.328e&#8722;08), positive regulation of osteoblast differentiation (9.3%; 1.255e&#8722;06), regulation of osteoblast differentiation (9.3%; 7.241e&#8722;06), transmembrane receptor protein serine/threonine kinase signaling pathway (11.6%; 1.533e&#8722;05), developmental process (67.4%; 2.095e&#8722;05)</td><td>50</td><td>12</td><td>1.49E&#8722;23</td></tr>
###xml 2124 2125 2124 2125 <td xmlns:xlink="http://www.w3.org/1999/xlink">3</td>
###xml 2125 2176 2125 2176 <td xmlns:xlink="http://www.w3.org/1999/xlink">Neurofibromin, TXNIP (VDUP1), REA, DEDD, DEDD2, ...</td>
###xml 2176 2442 2176 2442 <td xmlns:xlink="http://www.w3.org/1999/xlink">Regulation of apoptosis (45.5%; 2.153e&#8722;13), regulation of programmed cell death (45.5%; 2.710e&#8722;13), regulation of developmental process (52.3%; 2.099e&#8722;12), Ras protein signal transduction (22.7%; 1.044e&#8722;11), negative regulation of cellular process (54.5%; 1.944e&#8722;11)</td>
###xml 2442 2444 2442 2444 <td xmlns:xlink="http://www.w3.org/1999/xlink">50</td>
###xml 2444 2446 2444 2446 <td xmlns:xlink="http://www.w3.org/1999/xlink">10</td>
###xml 2446 2454 2446 2454 <td xmlns:xlink="http://www.w3.org/1999/xlink">9.99E&#8722;19</td>
###xml 2124 2454 2124 2454 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>3</td><td>Neurofibromin, TXNIP (VDUP1), REA, DEDD, DEDD2, ...</td><td>Regulation of apoptosis (45.5%; 2.153e&#8722;13), regulation of programmed cell death (45.5%; 2.710e&#8722;13), regulation of developmental process (52.3%; 2.099e&#8722;12), Ras protein signal transduction (22.7%; 1.044e&#8722;11), negative regulation of cellular process (54.5%; 1.944e&#8722;11)</td><td>50</td><td>10</td><td>9.99E&#8722;19</td></tr>
###xml 2454 2456 2454 2456 <td xmlns:xlink="http://www.w3.org/1999/xlink">No</td>
###xml 2456 2490 2456 2490 <td xmlns:xlink="http://www.w3.org/1999/xlink">Transcriptional Regulation Network</td>
###xml 2490 2502 2490 2502 <td xmlns:xlink="http://www.w3.org/1999/xlink">GO Processes</td>
###xml 2502 2513 2502 2513 <td xmlns:xlink="http://www.w3.org/1999/xlink">Total nodes</td>
###xml 2513 2523 2513 2523 <td xmlns:xlink="http://www.w3.org/1999/xlink">Root nodes</td>
###xml 2523 2524 2523 2524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2523 2530 2523 2530 <td xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic>-Value</td>
###xml 2454 2530 2454 2530 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>No</td><td>Transcriptional Regulation Network</td><td>GO Processes</td><td>Total nodes</td><td>Root nodes</td><td><italic>p</italic>-Value</td></tr>
###xml 2530 2531 2530 2531 <td xmlns:xlink="http://www.w3.org/1999/xlink">4</td>
###xml 2531 2536 2531 2536 <td xmlns:xlink="http://www.w3.org/1999/xlink">c-Myc</td>
###xml 2536 2779 2536 2779 <td xmlns:xlink="http://www.w3.org/1999/xlink">Positive regulation of mitotic cell cycle (25.0%; 1.015e&#8722;05), cell cycle (62.5%; 3.803e&#8722;05), regulation of mitotic cell cycle (37.5%; 5.661e&#8722;05), regulation of cell cycle (50.0%; 5.920e&#8722;05), positive regulation of cell cycle (25.0%; 3.432e&#8722;04)</td>
###xml 2779 2780 2779 2780 <td xmlns:xlink="http://www.w3.org/1999/xlink">9</td>
###xml 2780 2781 2780 2781 <td xmlns:xlink="http://www.w3.org/1999/xlink">8</td>
###xml 2781 2789 2781 2789 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.02E&#8722;22</td>
###xml 2530 2789 2530 2789 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>4</td><td>c-Myc</td><td>Positive regulation of mitotic cell cycle (25.0%; 1.015e&#8722;05), cell cycle (62.5%; 3.803e&#8722;05), regulation of mitotic cell cycle (37.5%; 5.661e&#8722;05), regulation of cell cycle (50.0%; 5.920e&#8722;05), positive regulation of cell cycle (25.0%; 3.432e&#8722;04)</td><td>9</td><td>8</td><td>4.02E&#8722;22</td></tr>
###xml 2789 2790 2789 2790 <td xmlns:xlink="http://www.w3.org/1999/xlink">5</td>
###xml 2790 2794 2790 2794 <td xmlns:xlink="http://www.w3.org/1999/xlink">ESR1</td>
###xml 2794 3061 2794 3061 <td xmlns:xlink="http://www.w3.org/1999/xlink">Response to hormone stimulus (57.1%; 2.915e&#8722;05), response to endogenous stimulus (57.1%; 3.184e&#8722;05), response to organic nitrogen (28.6%; 1.001e&#8722;04), response to steroid hormone stimulus (42.9%; 2.113e&#8722;04), negative regulation of hydrolase activity (28.6%; 2.580e&#8722;04)</td>
###xml 3061 3062 3061 3062 <td xmlns:xlink="http://www.w3.org/1999/xlink">8</td>
###xml 3062 3063 3062 3063 <td xmlns:xlink="http://www.w3.org/1999/xlink">7</td>
###xml 3063 3071 3063 3071 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.31E&#8722;19</td>
###xml 2789 3071 2789 3071 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>5</td><td>ESR1</td><td>Response to hormone stimulus (57.1%; 2.915e&#8722;05), response to endogenous stimulus (57.1%; 3.184e&#8722;05), response to organic nitrogen (28.6%; 1.001e&#8722;04), response to steroid hormone stimulus (42.9%; 2.113e&#8722;04), negative regulation of hydrolase activity (28.6%; 2.580e&#8722;04)</td><td>8</td><td>7</td><td>2.31E&#8722;19</td></tr>
###xml 3071 3072 3071 3072 <td xmlns:xlink="http://www.w3.org/1999/xlink">6</td>
###xml 3072 3075 3072 3075 <td xmlns:xlink="http://www.w3.org/1999/xlink">p53</td>
###xml 3075 3339 3075 3339 <td xmlns:xlink="http://www.w3.org/1999/xlink">Response to organic nitrogen (28.6%; 1.001e&#8722;04), positive regulation of cell cycle (28.6%; 2.580e&#8722;04), regulation of apoptosis (57.1%; 4.295e&#8722;04), nucleic acid&#8211;protein covalent cross-linking (14.3%; 4.446e&#8722;04), RNA&#8211;protein covalent cross-linking (14.3%; 4.446e&#8722;04)</td>
###xml 3339 3340 3339 3340 <td xmlns:xlink="http://www.w3.org/1999/xlink">8</td>
###xml 3340 3341 3340 3341 <td xmlns:xlink="http://www.w3.org/1999/xlink">7</td>
###xml 3341 3349 3341 3349 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.31E&#8722;19</td>
###xml 3071 3349 3071 3349 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>6</td><td>p53</td><td>Response to organic nitrogen (28.6%; 1.001e&#8722;04), positive regulation of cell cycle (28.6%; 2.580e&#8722;04), regulation of apoptosis (57.1%; 4.295e&#8722;04), nucleic acid&#8211;protein covalent cross-linking (14.3%; 4.446e&#8722;04), RNA&#8211;protein covalent cross-linking (14.3%; 4.446e&#8722;04)</td><td>8</td><td>7</td><td>2.31E&#8722;19</td></tr>
###xml 1461 3349 1461 3349 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>No</td><td>General Molecular Network</td><td>GO Processes</td><td>Total nodes</td><td>Root nodes</td><td><italic>p</italic>-Value</td></tr><tr><td>1</td><td>ADAM19, SLC25A10, CDC14a, UBE2E3, TXNIP (VDUP1), ...</td><td>Sulfate transport (8.1%; 7.943e&#8722;06), cell division (18.9%; 1.334e&#8722;05), mitosis (16.2%; 1.414e&#8722;05), M phase of mitotic cell cycle (16.2%; 1.598e&#8722;05), M phase (18.9%; 1.854e&#8722;05)</td><td>50</td><td>13</td><td>4.38E&#8722;26</td></tr><tr><td>2</td><td>REA, NLK, Chordin-like 1, Copine-1, ...</td><td>BMP signaling pathway (11.6%; 8.328e&#8722;08), positive regulation of osteoblast differentiation (9.3%; 1.255e&#8722;06), regulation of osteoblast differentiation (9.3%; 7.241e&#8722;06), transmembrane receptor protein serine/threonine kinase signaling pathway (11.6%; 1.533e&#8722;05), developmental process (67.4%; 2.095e&#8722;05)</td><td>50</td><td>12</td><td>1.49E&#8722;23</td></tr><tr><td>3</td><td>Neurofibromin, TXNIP (VDUP1), REA, DEDD, DEDD2, ...</td><td>Regulation of apoptosis (45.5%; 2.153e&#8722;13), regulation of programmed cell death (45.5%; 2.710e&#8722;13), regulation of developmental process (52.3%; 2.099e&#8722;12), Ras protein signal transduction (22.7%; 1.044e&#8722;11), negative regulation of cellular process (54.5%; 1.944e&#8722;11)</td><td>50</td><td>10</td><td>9.99E&#8722;19</td></tr><tr><td>No</td><td>Transcriptional Regulation Network</td><td>GO Processes</td><td>Total nodes</td><td>Root nodes</td><td><italic>p</italic>-Value</td></tr><tr><td>4</td><td>c-Myc</td><td>Positive regulation of mitotic cell cycle (25.0%; 1.015e&#8722;05), cell cycle (62.5%; 3.803e&#8722;05), regulation of mitotic cell cycle (37.5%; 5.661e&#8722;05), regulation of cell cycle (50.0%; 5.920e&#8722;05), positive regulation of cell cycle (25.0%; 3.432e&#8722;04)</td><td>9</td><td>8</td><td>4.02E&#8722;22</td></tr><tr><td>5</td><td>ESR1</td><td>Response to hormone stimulus (57.1%; 2.915e&#8722;05), response to endogenous stimulus (57.1%; 3.184e&#8722;05), response to organic nitrogen (28.6%; 1.001e&#8722;04), response to steroid hormone stimulus (42.9%; 2.113e&#8722;04), negative regulation of hydrolase activity (28.6%; 2.580e&#8722;04)</td><td>8</td><td>7</td><td>2.31E&#8722;19</td></tr><tr><td>6</td><td>p53</td><td>Response to organic nitrogen (28.6%; 1.001e&#8722;04), positive regulation of cell cycle (28.6%; 2.580e&#8722;04), regulation of apoptosis (57.1%; 4.295e&#8722;04), nucleic acid&#8211;protein covalent cross-linking (14.3%; 4.446e&#8722;04), RNA&#8211;protein covalent cross-linking (14.3%; 4.446e&#8722;04)</td><td>8</td><td>7</td><td>2.31E&#8722;19</td></tr></tbody>
###xml 1461 3349 1461 3349 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><tbody><tr><td>No</td><td>General Molecular Network</td><td>GO Processes</td><td>Total nodes</td><td>Root nodes</td><td><italic>p</italic>-Value</td></tr><tr><td>1</td><td>ADAM19, SLC25A10, CDC14a, UBE2E3, TXNIP (VDUP1), ...</td><td>Sulfate transport (8.1%; 7.943e&#8722;06), cell division (18.9%; 1.334e&#8722;05), mitosis (16.2%; 1.414e&#8722;05), M phase of mitotic cell cycle (16.2%; 1.598e&#8722;05), M phase (18.9%; 1.854e&#8722;05)</td><td>50</td><td>13</td><td>4.38E&#8722;26</td></tr><tr><td>2</td><td>REA, NLK, Chordin-like 1, Copine-1, ...</td><td>BMP signaling pathway (11.6%; 8.328e&#8722;08), positive regulation of osteoblast differentiation (9.3%; 1.255e&#8722;06), regulation of osteoblast differentiation (9.3%; 7.241e&#8722;06), transmembrane receptor protein serine/threonine kinase signaling pathway (11.6%; 1.533e&#8722;05), developmental process (67.4%; 2.095e&#8722;05)</td><td>50</td><td>12</td><td>1.49E&#8722;23</td></tr><tr><td>3</td><td>Neurofibromin, TXNIP (VDUP1), REA, DEDD, DEDD2, ...</td><td>Regulation of apoptosis (45.5%; 2.153e&#8722;13), regulation of programmed cell death (45.5%; 2.710e&#8722;13), regulation of developmental process (52.3%; 2.099e&#8722;12), Ras protein signal transduction (22.7%; 1.044e&#8722;11), negative regulation of cellular process (54.5%; 1.944e&#8722;11)</td><td>50</td><td>10</td><td>9.99E&#8722;19</td></tr><tr><td>No</td><td>Transcriptional Regulation Network</td><td>GO Processes</td><td>Total nodes</td><td>Root nodes</td><td><italic>p</italic>-Value</td></tr><tr><td>4</td><td>c-Myc</td><td>Positive regulation of mitotic cell cycle (25.0%; 1.015e&#8722;05), cell cycle (62.5%; 3.803e&#8722;05), regulation of mitotic cell cycle (37.5%; 5.661e&#8722;05), regulation of cell cycle (50.0%; 5.920e&#8722;05), positive regulation of cell cycle (25.0%; 3.432e&#8722;04)</td><td>9</td><td>8</td><td>4.02E&#8722;22</td></tr><tr><td>5</td><td>ESR1</td><td>Response to hormone stimulus (57.1%; 2.915e&#8722;05), response to endogenous stimulus (57.1%; 3.184e&#8722;05), response to organic nitrogen (28.6%; 1.001e&#8722;04), response to steroid hormone stimulus (42.9%; 2.113e&#8722;04), negative regulation of hydrolase activity (28.6%; 2.580e&#8722;04)</td><td>8</td><td>7</td><td>2.31E&#8722;19</td></tr><tr><td>6</td><td>p53</td><td>Response to organic nitrogen (28.6%; 1.001e&#8722;04), positive regulation of cell cycle (28.6%; 2.580e&#8722;04), regulation of apoptosis (57.1%; 4.295e&#8722;04), nucleic acid&#8211;protein covalent cross-linking (14.3%; 4.446e&#8722;04), RNA&#8211;protein covalent cross-linking (14.3%; 4.446e&#8722;04)</td><td>8</td><td>7</td><td>2.31E&#8722;19</td></tr></tbody></table>
###xml 3349 4011 3349 4011 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44">Here we show information about the top literature subnetworks with significant enrichment for genes of the WIPF1 module using two modes of analysis in the metacore software. Networks 1, 2, and 3 were derived using a large literature network considering all types of molecular interactions. Networks 4, 5, and 6 resulted from an enrichment analysis of subnetworks centered around transcription factors. Column &#8220;GO processes&#8221; shows Gene Ontology (GO) categories that are enriched in a subnetwork. Significance of enrichment of gene groups (be it WIPF1 coexpressed genes or genes associated with GO categories) in subnetworks was assessed using hypergeometric tests</p>
###xml 3349 4011 3349 4011 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44">Here we show information about the top literature subnetworks with significant enrichment for genes of the WIPF1 module using two modes of analysis in the metacore software. Networks 1, 2, and 3 were derived using a large literature network considering all types of molecular interactions. Networks 4, 5, and 6 resulted from an enrichment analysis of subnetworks centered around transcription factors. Column &#8220;GO processes&#8221; shows Gene Ontology (GO) categories that are enriched in a subnetwork. Significance of enrichment of gene groups (be it WIPF1 coexpressed genes or genes associated with GO categories) in subnetworks was assessed using hypergeometric tests</p></table-wrap-foot>
###xml 1360 4011 1360 4011 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="43">Summaries of top literature subnetworks enriched with genes from the WIPF1 coexpression module</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>No</td><td>General Molecular Network</td><td>GO Processes</td><td>Total nodes</td><td>Root nodes</td><td><italic>p</italic>-Value</td></tr><tr><td>1</td><td>ADAM19, SLC25A10, CDC14a, UBE2E3, TXNIP (VDUP1), ...</td><td>Sulfate transport (8.1%; 7.943e&#8722;06), cell division (18.9%; 1.334e&#8722;05), mitosis (16.2%; 1.414e&#8722;05), M phase of mitotic cell cycle (16.2%; 1.598e&#8722;05), M phase (18.9%; 1.854e&#8722;05)</td><td>50</td><td>13</td><td>4.38E&#8722;26</td></tr><tr><td>2</td><td>REA, NLK, Chordin-like 1, Copine-1, ...</td><td>BMP signaling pathway (11.6%; 8.328e&#8722;08), positive regulation of osteoblast differentiation (9.3%; 1.255e&#8722;06), regulation of osteoblast differentiation (9.3%; 7.241e&#8722;06), transmembrane receptor protein serine/threonine kinase signaling pathway (11.6%; 1.533e&#8722;05), developmental process (67.4%; 2.095e&#8722;05)</td><td>50</td><td>12</td><td>1.49E&#8722;23</td></tr><tr><td>3</td><td>Neurofibromin, TXNIP (VDUP1), REA, DEDD, DEDD2, ...</td><td>Regulation of apoptosis (45.5%; 2.153e&#8722;13), regulation of programmed cell death (45.5%; 2.710e&#8722;13), regulation of developmental process (52.3%; 2.099e&#8722;12), Ras protein signal transduction (22.7%; 1.044e&#8722;11), negative regulation of cellular process (54.5%; 1.944e&#8722;11)</td><td>50</td><td>10</td><td>9.99E&#8722;19</td></tr><tr><td>No</td><td>Transcriptional Regulation Network</td><td>GO Processes</td><td>Total nodes</td><td>Root nodes</td><td><italic>p</italic>-Value</td></tr><tr><td>4</td><td>c-Myc</td><td>Positive regulation of mitotic cell cycle (25.0%; 1.015e&#8722;05), cell cycle (62.5%; 3.803e&#8722;05), regulation of mitotic cell cycle (37.5%; 5.661e&#8722;05), regulation of cell cycle (50.0%; 5.920e&#8722;05), positive regulation of cell cycle (25.0%; 3.432e&#8722;04)</td><td>9</td><td>8</td><td>4.02E&#8722;22</td></tr><tr><td>5</td><td>ESR1</td><td>Response to hormone stimulus (57.1%; 2.915e&#8722;05), response to endogenous stimulus (57.1%; 3.184e&#8722;05), response to organic nitrogen (28.6%; 1.001e&#8722;04), response to steroid hormone stimulus (42.9%; 2.113e&#8722;04), negative regulation of hydrolase activity (28.6%; 2.580e&#8722;04)</td><td>8</td><td>7</td><td>2.31E&#8722;19</td></tr><tr><td>6</td><td>p53</td><td>Response to organic nitrogen (28.6%; 1.001e&#8722;04), positive regulation of cell cycle (28.6%; 2.580e&#8722;04), regulation of apoptosis (57.1%; 4.295e&#8722;04), nucleic acid&#8211;protein covalent cross-linking (14.3%; 4.446e&#8722;04), RNA&#8211;protein covalent cross-linking (14.3%; 4.446e&#8722;04)</td><td>8</td><td>7</td><td>2.31E&#8722;19</td></tr></tbody></table><table-wrap-foot><p textid="44">Here we show information about the top literature subnetworks with significant enrichment for genes of the WIPF1 module using two modes of analysis in the metacore software. Networks 1, 2, and 3 were derived using a large literature network considering all types of molecular interactions. Networks 4, 5, and 6 resulted from an enrichment analysis of subnetworks centered around transcription factors. Column &#8220;GO processes&#8221; shows Gene Ontology (GO) categories that are enriched in a subnetwork. Significance of enrichment of gene groups (be it WIPF1 coexpressed genes or genes associated with GO categories) in subnetworks was assessed using hypergeometric tests</p></table-wrap-foot></table-wrap>
###xml 4011 4017 4011 4017 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;6</label>
###xml 4367 4373 4367 4373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 4420 4437 4420 4437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">colors of circles</italic>
###xml 4505 4510 4505 4510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 4522 4525 4522 4525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 4535 4539 4535 4539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 4017 4548 4017 4548 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="45">Fused transcriptional regulation network of genes of the WIPF1 module that are regulated by c-myc, ESR1 or p53. Here we show the fused network of WIPF1 co-expressed genes that are linked to c-myc, ESR1 or p53 according to literature evidence. The legend on the left depicts the graphical symbols that describe the type of protein in the network. The <italic>arrows</italic> indicate the direction of the regulation. The <italic>colors of circles</italic> around gene names represent the coupling to transcription factors: <italic>green</italic> for c-myc, <italic>red</italic> for p53, <italic>blue</italic> for ESR1</p>
###xml 4017 4548 4017 4548 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="45">Fused transcriptional regulation network of genes of the WIPF1 module that are regulated by c-myc, ESR1 or p53. Here we show the fused network of WIPF1 co-expressed genes that are linked to c-myc, ESR1 or p53 according to literature evidence. The legend on the left depicts the graphical symbols that describe the type of protein in the network. The <italic>arrows</italic> indicate the direction of the regulation. The <italic>colors of circles</italic> around gene names represent the coupling to transcription factors: <italic>green</italic> for c-myc, <italic>red</italic> for p53, <italic>blue</italic> for ESR1</p></caption>
###xml 4548 4548 4548 4548 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="109_2009_467_Fig6_HTML" id="MO6"/>
###xml 4011 4548 4011 4548 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig6"><label>Fig.&#160;6</label><caption><p textid="45">Fused transcriptional regulation network of genes of the WIPF1 module that are regulated by c-myc, ESR1 or p53. Here we show the fused network of WIPF1 co-expressed genes that are linked to c-myc, ESR1 or p53 according to literature evidence. The legend on the left depicts the graphical symbols that describe the type of protein in the network. The <italic>arrows</italic> indicate the direction of the regulation. The <italic>colors of circles</italic> around gene names represent the coupling to transcription factors: <italic>green</italic> for c-myc, <italic>red</italic> for p53, <italic>blue</italic> for ESR1</p></caption><graphic position="anchor" xlink:href="109_2009_467_Fig6_HTML" id="MO6"/></fig>
We next addressed the question which functional themes are dominating the list of 112 WIPF1-coexpressed genes. We investigated the genes of the WIPF1 module by mining of literature networks using the metacore software. We identified several gene networks that were highly enriched with genes of the WIPF1 module (see Table 2) and are therefore suited to highlight the function of the WIPF1 module. First, we took all different types of functional links into account (protein-protein interactions, enzymatic reactions, transcriptional regulation, etc.) for building of literature subnetworks. We identified three subnetworks that are enriched with gene functions in cancer-relevant processes like mitosis and apoptosis as important themes among WIPF1 signature-induced networks (see Table 2). By focusing the analysis on literature networks centered at transcription factors, three subnetworks stood out with 21 genes linked via the oncogenic transcription factors c-myc, ESR1, and p53 (see Table 2 and Fig. 6). For these three factors, there are 17 genes with literature evidence that c-myc, ESR1, and/or p53 regulate their transcription. Thus, literature network analysis could link the WIPF1 signature to several functional themes related to cancer biology with high significance: mitosis and proliferation, apoptosis, the estrogen receptor, c-myc, and p53. Table 2Summaries of top literature subnetworks enriched with genes from the WIPF1 coexpression moduleNoGeneral Molecular NetworkGO ProcessesTotal nodesRoot nodesp-Value1ADAM19, SLC25A10, CDC14a, UBE2E3, TXNIP (VDUP1), ...Sulfate transport (8.1%; 7.943e-06), cell division (18.9%; 1.334e-05), mitosis (16.2%; 1.414e-05), M phase of mitotic cell cycle (16.2%; 1.598e-05), M phase (18.9%; 1.854e-05)50134.38E-262REA, NLK, Chordin-like 1, Copine-1, ...BMP signaling pathway (11.6%; 8.328e-08), positive regulation of osteoblast differentiation (9.3%; 1.255e-06), regulation of osteoblast differentiation (9.3%; 7.241e-06), transmembrane receptor protein serine/threonine kinase signaling pathway (11.6%; 1.533e-05), developmental process (67.4%; 2.095e-05)50121.49E-233Neurofibromin, TXNIP (VDUP1), REA, DEDD, DEDD2, ...Regulation of apoptosis (45.5%; 2.153e-13), regulation of programmed cell death (45.5%; 2.710e-13), regulation of developmental process (52.3%; 2.099e-12), Ras protein signal transduction (22.7%; 1.044e-11), negative regulation of cellular process (54.5%; 1.944e-11)50109.99E-19NoTranscriptional Regulation NetworkGO ProcessesTotal nodesRoot nodesp-Value4c-MycPositive regulation of mitotic cell cycle (25.0%; 1.015e-05), cell cycle (62.5%; 3.803e-05), regulation of mitotic cell cycle (37.5%; 5.661e-05), regulation of cell cycle (50.0%; 5.920e-05), positive regulation of cell cycle (25.0%; 3.432e-04)984.02E-225ESR1Response to hormone stimulus (57.1%; 2.915e-05), response to endogenous stimulus (57.1%; 3.184e-05), response to organic nitrogen (28.6%; 1.001e-04), response to steroid hormone stimulus (42.9%; 2.113e-04), negative regulation of hydrolase activity (28.6%; 2.580e-04)872.31E-196p53Response to organic nitrogen (28.6%; 1.001e-04), positive regulation of cell cycle (28.6%; 2.580e-04), regulation of apoptosis (57.1%; 4.295e-04), nucleic acid-protein covalent cross-linking (14.3%; 4.446e-04), RNA-protein covalent cross-linking (14.3%; 4.446e-04)872.31E-19Here we show information about the top literature subnetworks with significant enrichment for genes of the WIPF1 module using two modes of analysis in the metacore software. Networks 1, 2, and 3 were derived using a large literature network considering all types of molecular interactions. Networks 4, 5, and 6 resulted from an enrichment analysis of subnetworks centered around transcription factors. Column "GO processes" shows Gene Ontology (GO) categories that are enriched in a subnetwork. Significance of enrichment of gene groups (be it WIPF1 coexpressed genes or genes associated with GO categories) in subnetworks was assessed using hypergeometric testsFig. 6Fused transcriptional regulation network of genes of the WIPF1 module that are regulated by c-myc, ESR1 or p53. Here we show the fused network of WIPF1 co-expressed genes that are linked to c-myc, ESR1 or p53 according to literature evidence. The legend on the left depicts the graphical symbols that describe the type of protein in the network. The arrows indicate the direction of the regulation. The colors of circles around gene names represent the coupling to transcription factors: green for c-myc, red for p53, blue for ESR1
###end p 42
###begin p 43
Summaries of top literature subnetworks enriched with genes from the WIPF1 coexpression module
###end p 43
###begin p 44
Here we show information about the top literature subnetworks with significant enrichment for genes of the WIPF1 module using two modes of analysis in the metacore software. Networks 1, 2, and 3 were derived using a large literature network considering all types of molecular interactions. Networks 4, 5, and 6 resulted from an enrichment analysis of subnetworks centered around transcription factors. Column "GO processes" shows Gene Ontology (GO) categories that are enriched in a subnetwork. Significance of enrichment of gene groups (be it WIPF1 coexpressed genes or genes associated with GO categories) in subnetworks was assessed using hypergeometric tests
###end p 44
###begin p 45
###xml 350 356 350 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 403 420 403 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">colors of circles</italic>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 505 508 505 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 518 522 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
Fused transcriptional regulation network of genes of the WIPF1 module that are regulated by c-myc, ESR1 or p53. Here we show the fused network of WIPF1 co-expressed genes that are linked to c-myc, ESR1 or p53 according to literature evidence. The legend on the left depicts the graphical symbols that describe the type of protein in the network. The arrows indicate the direction of the regulation. The colors of circles around gene names represent the coupling to transcription factors: green for c-myc, red for p53, blue for ESR1
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 1849 1851 1849 1851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">38</xref>
###xml 775 783 <span type="species:ncbi:9606">patients</span>
The hypothesis that the WIPF1 gene is important for cancer development was based on two facts. First, its encoded WIP protein interacts with the Wiskott-Aldrich syndrome protein WASP through a surface that is affected by a WASP mutation, and Wiskott-Aldrich syndrome predisposes to leukemia and lymphoma. Second, expression levels of the WIP protein influence the migratory and differentiation properties of fibroblasts. It has not been studied so far how the expression of the WIPF1 gene is regulated and if its coexpression neighborhood provides an additional link to cancer. Here, we show that there exists a module of genes that is coexpressed with WIPF1 in colorectal cancers. The majority of genes in this module show a characteristic down-regulation in several cancer patients with longer survival time or time to relapse, also in other cancer types than colorectal cancer. We found that the module genes do not overlap with the frequently rediscovered "proliferation" signature that is regulated during cancer cell mitosis. Instead, a large number of genes of the WIPF1 coexpression module have poorly characterized functions. Only single genes link directly to cancer-relevant processes like proliferation and apoptosis. However, we could show that the expression profile of the WIPF1 signature correlates significantly with expression profile of the Rosenwald proliferation signature. Literature networks revealed that the link of the WIPF1 module to proliferation can partly be explained by the fact that a large fraction of WIPF1 module genes are known transcriptional targets of oncogenic transcription factors like c-myc, ESR1, or p53. In this context, it is interesting to note that estrogen receptor signaling is not only of importance for breast cancers, but also apparently able to modulate the aggressiveness of prostate cancers [38]. It is tempting to hypothesize that keeping the expression of the WIPF1 module in a low expression state is causative for a less aggressive cancer phenotype, e.g., by inhibition of WIPF1/WASP-related cytoskeletal remodeling that coincides with a reduced ability of cells to migrate and metastasize.
###end p 47
###begin p 48
###xml 131 139 <span type="species:ncbi:9606">patients</span>
In conclusion, we presented a module of WIPF1-coexpressed genes. The expression signature of this module could be used to identify patients with better prognosis with respect to relapse or survival in expression data sets of three different tumor types, colorectal cancer, breast cancer, and high-grade glioma. The WIPF1 coexpressed genes seem to be linked to proliferation and apoptosis possibly by regulation through c-myc, ESR1, and p53. We propose the WIPF1 signature as an alternative predictor of breast, brain, and colorectal cancer prognosis.
###end p 48
###begin title 49
Electronic supplementary material
###end title 49
###begin p 50
Below is the link to the electronic supplementary material. 
###end p 50
###begin p 51
(XLS 23 kb)
###end p 51
###begin p 52
(XLS 27 kb)
###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
We thank Anja von Heydebreck for critical reading of the manuscript and valuable comments.
###end p 54
###begin p 55
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Disclosure of potential conflict of interests</bold>
Disclosure of potential conflict of interests The authors declare that they have no conflicting interests related to this study.
###end p 55
###begin p 56
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 56
###begin title 57
References
###end title 57
###begin article-title 58
A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization
###end article-title 58
###begin article-title 59
WIP, a protein associated with Wiskott-Aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells
###end article-title 59
###begin article-title 60
Structure of the N-WASP EVH1 domain-WIP complex: insight into the molecular basis of Wiskott-Aldrich Syndrome
###end article-title 60
###begin article-title 61
Multiple WASP-interacting protein recognition motifs are required for a functional interaction with N-WASP
###end article-title 61
###begin article-title 62
###xml 9 13 <span type="species:ncbi:10090">mice</span>
WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome
###end article-title 62
###begin article-title 63
WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP)
###end article-title 63
###begin article-title 64
WIP is essential for lytic granule polarization and NK cell cytotoxicity
###end article-title 64
###begin article-title 65
###xml 82 92 82 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 82 92 <span type="species:ncbi:7227">Drosophila</span>
WIP/WASp-based actin-polymerization machinery is essential for myoblast fusion in Drosophila
###end article-title 65
###begin article-title 66
Requirement for a complex of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein in podosome formation in macrophages
###end article-title 66
###begin article-title 67
A role for WASP Interacting Protein, WIP, in fibroblast adhesion, spreading and migration
###end article-title 67
###begin article-title 68
Broad patterns of gene expression revealed by clustering analysis of tumour and normal colon tissues probed by oligonucleotide arrays
###end article-title 68
###begin article-title 69
Relationship of gene expression and chromosomal abnormalities in colorectal cancer
###end article-title 69
###begin article-title 70
Genome-wide expression patterns of invasion front, inner tumour mass and surrounding normal epithelium of colorectal tumours
###end article-title 70
###begin article-title 71
A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer
###end article-title 71
###begin article-title 72
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 157 162 <span type="species:ncbi:9606">human</span>
Transcriptional profiles of intestinal tumours in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumours
###end article-title 72
###begin article-title 73
Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays
###end article-title 73
###begin article-title 74
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
###xml 110 115 <span type="species:ncbi:9606">human</span>
Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumour models and human colon cancer
###end article-title 74
###begin article-title 75
Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumour tissues and normal epithelia
###end article-title 75
###begin article-title 76
Gene expression profiles of colorectal carcinoma in response to neo-adjuvant chemotherapy
###end article-title 76
###begin article-title 77
Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonist
###end article-title 77
###begin article-title 78
Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin
###end article-title 78
###begin article-title 79
Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy
###end article-title 79
###begin article-title 80
Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer
###end article-title 80
###begin article-title 81
Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and III
###end article-title 81
###begin article-title 82
Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumour progression
###end article-title 82
###begin article-title 83
Classification of Dukes' B and C colorectal cancers using expression arrays
###end article-title 83
###begin article-title 84
Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters
###end article-title 84
###begin article-title 85
Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas
###end article-title 85
###begin article-title 86
Microarray versus conventional prediction of lymph node metastasis in colorectal carcinoma
###end article-title 86
###begin article-title 87
Molecular signature for lymphatic metastasis in colorectal carcinomas
###end article-title 87
###begin article-title 88
Whole genome analysis for liver metastasis gene signatures in colorectal cancer
###end article-title 88
###begin article-title 89
The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer
###end article-title 89
###begin article-title 90
Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer
###end article-title 90
###begin article-title 91
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
###end article-title 91
###begin article-title 92
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
###end article-title 92
###begin article-title 93
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
###end article-title 93
###begin article-title 94
Challenges in projecting clustering results across gene expression-profiling datasets
###end article-title 94
###begin article-title 95
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer
###end article-title 95
###begin p 96
Eike Staub and Joern Groene contributed equally as first author for this journal.
###end p 96
###begin p 97
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electronic supplementary material</bold>
Electronic supplementary material
###end p 97
###begin p 98
The online version of this article (doi:10.1007/s00109-009-0467-y) contains supplementary material, which is available to authorized users.
###end p 98

